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2 INTRODUCTION 
2.1 Nucleic acid-based therapies 
Gene therapy offers a wide spectrum of approaches including regulation, repair and 
replacement of genes which directly cure at the molecular genetic origin of the disease. For 
monogenetic diseases like cystic fibrosis [1], severe combined immunodeficiency (SCID) [2] 
and hyperlipidemia [3], the replacement of the defective gene is a successfully used 
approach. Furthermore, the interference on the genetic level is a promising option for 
cancer, which is usually promoted by complex genetic disregulations and still constitutes an 
often incurable disease and one of the main causes of death. 
The first gene transfer in mammalian cells was already documented over 50 years ago [4]. 
Only some years later Rogers and Pfuderer provided evidence of the first viral gene transfer 
in plants [5]. Over the last decades the field of gene therapy expanded tremendously in 
regard to vector diversity as well as the applied type of nucleic acid. 
In addition to the initial strategy of successfully substituting defective genes with the 
corresponding intact gene inserted into plasmid DNA (pDNA), the option of suppressing 
pathogenic genes has emerged as a widely-used tool. Such a blockade is based on specific 
complementary binding of an antisense nucleic acid strand to messenger RNA (mRNA) in the 
RNA-induced silencing complex (RISC), leading to enzymatic mRNA degradation or to steric 
hindrance preventing the translation into the encoded protein. Classical approaches for 
specific gene suppression include the application of single-stranded oligodesoxy-
ribonucleotides (ODNs), whereas RNA interference (RNAi) was discovered as a novel strategy 
for the silencing of a specific gene in nematodes in 1998 by Fire et al. [6]. However, this 
technique was not as effective in mammalian cells, where the initially applied long double-
stranded RNA (dsRNA) with over 30 base pairs (bp) induced immune reactions and cell 
death.  It was only with the direct application of the shorter 21 bp small interfering RNA 
(siRNA) that effective gene silencing was achieved in mammalian cells at the same time 
circumventing immune responses [7]. This finding marks a milestone in the development of 
therapeutic nucleic acids for gene silencing. Another key discovery in the 1990s was the 
existence of genes which instead of encoding for proteins, resulted in the production of 
small RNA molecules, the so-called microRNAs (miRNAs) [8]. These widely found non-coding 
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miRNAs regulate the expression of specific genes by interference with the mRNA, allowing 
for phenotypic fine-tuning [9, 10]. As many miRNA targets were identified to be oncogenes, 
the application of exogenous miRNA provides a promising therapeutic option for cancer. 
Conversely, inhibition of endogenous miRNA by antagomirs [11] is an interesting approach 
for inactivation of miRNAs targeting tumor suppressors (oncomirs). Another exciting concept 
is the application of aptamers, 56-120 nucleotides long single-stranded RNAs, which due to 
their special 3D structure are able to bind to their targets with high specificity and affinity 
[12]. Although preferentially used for diagnostics or targeted delivery, such as for the 
previously described siRNAs [13], aptamers are also applied as therapeutic principle itself. 
The most encouraging example is given by Pegaptanib, an aptamer against the Vascular 
endothelial growth factor (VEGF), that received FDA approval as a therapeutic against age-
related macular degeneration (AMD) in 2004 [14].   
Besides the exploration of different mechanistic approaches for the application of nucleic 
acid-based therapies, a crucial step towards promising therapeutic options was the 
introduction of a variety of chemical modifications leading to a better performance of the 
nucleic acid itself. Accomplished optimizations include the decrease of susceptibility to 
degradation by nucleases present in biological fluids, the avoidance of side effects caused by 
immune reactions or off-target downregulation, as well as the increase of potency [15]. In 
this context the RNA modification of the 2´-OH groups such as the 2´-O-methyl or 2´-fluoro 
became a widely-used strategy. Connecting the 2´-O with the 4´-C via a methylene bridge 
results in the locked nucleic acids (LNAs) adopting a blocked A-conformation, which provides 
a great enhancement in thermostability [16, 17]. Other commonly used backbone 
modifications are phosphorothioate [18] or phosphorodiamidate morpholino oligomers 
(PMOs) [19]. 
Altogether the diversity of natural and chemically modified nucleic acids offers a wide 
spectrum of therapeutic approaches. Nevertheless, these can only lead to success in 
combination with appropriate carrier systems. 
2.2 Synthetic carrier systems for the delivery of nucleic acids 
2.2.1 Features of different therapeutic carrier types 
Inherent properties of nucleic acids like their anionic character, sizes up to the micrometer 
scale and instability in biological fluids emphasize the need for appropriate carrier systems in 
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order to use them as therapeutic principle. Although in more than 40 years of experience 
remarkable progress was made in the field of gene therapy with many approaches entering 
into clinical trials [20], the need for an ideal delivery system in regard to efficiency and 
biocompatibility has yet to be fulfilled. Important prerequisites for effective therapeutic 
application are the successful delivery to the desired site of action and subsequent release 
inside the target cells. The first step in this process is the packaging of the nucleic acid cargo 
into stable nanoparticles to prevent enzymatic degradation in the bloodstream after 
intravenous administration. At the same time particle aggregation and interaction with 
serum components have to be avoided, which can be achieved by appropriate shielding 
components. In this context PEGylation has become a popular strategy [21]. Accumulation at 
the target site can be accomplished via the enhanced permeability and retention effect 
(EPR), which exploits the leaky tumor vasculature and the insufficient lymphatic drainage in 
the tumor tissue for the enrichment of nanoparticles [22]. Besides this passive targeting 
effect, active cell targeting can be achieved through the attachment of specific targeting 
ligands enabeling receptor-mediated endocytosis preferentially into receptor overexpressing 
cells [23]. The next critical step is given by the endosomal escape. The rupture of the 
endosomal membrane can be conducted by lytic carrier domains as they are present in 
lipidic carriers [24], or via the proton sponge effect for carriers with proton buffering 
capacities at the relevant pH range [25]. In some cases, depending on the type of nucleic 
acid (e. g. siRNA), the place of action is reached in the cytosol and therefore the efficient and 
early endosomal escape is an essential demand. For pDNA further transport to the nucleus is 
required representing a further crucial step. In order to overcome all these extra- and 
intracellular barriers, a great variety of carriers with differing chemical and physical 
properties have been used so far. 
The first attempts of gene delivery were performed with viral vectors by exploiting their 
natural property of infecting cells and transferring their genetic information to the host. Due 
to their dynamic alignment to the conditions prevailing in the host, viruses turned out to be 
very efficient carrier systems [26]. However, despite these advantages and the first reported 
complete cure of SCID-X1 by viral gene therapy [2], many drawbacks are known connected 
to the use of viral vectors. These include a limited cargo loading, the elicitation of immune 
responses and most alarming the risk of promoting cancer by insertional mutagenesis [26].  
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In this context in recent times the field of synthetic carriers for gene delivery, which in most 
cases are cationic liposomes, peptides or polymers, has undergone enormous advances. 
Direct complexation of nucleic acids with cationic lipids results in the self-assembly of so-
called lipoplexes [27, 28]. Lipopolyplexes are formed by the addition of liposomes to pre-
formed polyplexes [29], whereas liposomes are characterized by the encapsulation of the 
nucleic acid in uni- or multilamellar lipid bilayers [30]. Nowadays lipid-based carriers 
constitute one of the most advanced fields of nucleic acid delivery by synthetic vectors, with 
several formulations entering into clinical trials [31]
(SNALPS), a carrier system consisting of PEGylated liposomes, showed success as 
therapeutics for liver diseases exploiting the effect of liver accumulation. Ongoing clinical 
trials include for example treatment of hypercholesterolemia or liver cancer [32, 33].  
Besides the lipid-mediated approaches, also polymer-based transfection agents like 
polyethylenimine (PEI) or polylysine (PLL) provided promising results entering into clinical 
trials [34-36]. The first clinical polyplex-mediated gene therapy trial in patients was based on 
an ex vivo approach using adenovirus-enhanced transferrinfection (AVET) [37, 38] for the 
transfection of the Interleukin 2 (IL-2) gene to autologous tumor cells of melanoma patients 
[39, 40]. The IL-2 expressing tumor cells were used as tumor vaccine, stimulating antitumoral 
effects due to immune response activation after intradermal injection [41]. Recently, a 
clinical trial was started to study the first targeted polymer-based siRNA carrier system in 
humans [42]. Based on cyclodextrin, Davis and coworkers designed a nanoparticle carrying 
PEGylation and transferrin ligands [43]. The transferrin receptor is overexpressed in many 
cancer types and therefore constitutes a well-known specific tumor target [44]. By detection 
of a specific mRNA cleavage product in tumor cells the authors provided the first evidence 
for RNAi in humans after systemic application [43]. 
2.2.2 Polydisperse versus precise carrier structures 
Since it was first demonstrated that PLL is capable of condensing DNA into nanosized 
structures in 1975 [45], gene delivery with cationic polymers became an extensively 
explored field. Among the synthetic polymers, PEI has emerged as a gold standard for gene 
delivery due to its high transfection efficiency. However, cytotoxicity and its polydisperse 
character constitute main drawbacks hampering the clinical application. After the first use as 
a gene delivery agent by Jean-Paul Behr and colleagues in 1995 [25], many optimizations 
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have been performed on PEI to improve its physicochemical and biological properties. 
Surface modification of branched PEI (brPEI) with neutral or negative moieties resulted in 
reduction of cytotoxicity [46, 47]. To tackle the problem of polydispersity, the synthesis was 
optimized by the use of sequence-controlled polymerization techniques [48, 49] or by 
additional purification steps like size exclusion chromatography helping to define the MW 
range of polymer-based carriers. Nevertheless, the mentioned techniques still do not 
provide complete sequence control. Up to now many approaches were developed and 
exploited to synthesize precise carriers. For nucleic acid delivery especially two techniques, 
the use of solid-phase synthesis for the development of peptide-based carriers and the 
assembly of dendrimers have gained importance [36, 50, 51]. Dendrimers consist of a core 
molecule and a defined amount of branches, which multiply with increasing generation 
number. Polyamidoamine (PAMAM) and polypropylenimine (PPI) are prominent examples 
for dendrimer-based nucleic acid delivery systems, not only in the original form, but also 
with diverse surface modifications in order to improve their properties [52-54]. Among the 
peptide-based carriers, the cell-penetrating peptides (CPPs) represent a widely used 
platform for the design of nucleic acid delivery systems [55] with encouraging results for 
pDNA [56, 57] as well as for siRNA delivery [58-60]. In the Wagner lab artificial amino acids 
containing the diaminoethane motif were designed for their use in the synthesis of 
sequence-defined carriers for DNA and siRNA delivery [61]. Furthermore, derivatization with 
an amino and carboxylic acid linker of functional domains, like PEG or the targeting ligand 
folic acid, makes them applicable to solid-phase synthesis. Combination with natural amino 
acids allowed the synthesis of a huge library of efficient carriers for DNA and siRNA delivery 
providing multifunctionality and maintaining control of the sequence at each position [62-
70].  
In some cases the applied chemistry comes across limitations for the synthesis of carriers 
with multifunctional domains, e.g. when certain domains are incompatible with specific 
reaction conditions necessary for the assembly of another domain, as it can be the case for 
peptide-oligonucleotide conjugate assembly on solid-phase [71]. Furthermore, already 
existing carriers can turn out not to be optimal for a certain application leading to the need 
for subsequent modification. In this context other approaches for the design of precise 
carriers, in particular specific conjugation techniques allowing the production of covalent 
conjugates, come into use. A widely-utilized method is the conjugation of activated thiols 
Introduction   13 
which result in biodegradable disulfide bonds. The activation of one reaction partner with a 
pyridylsulfenyl (Pys) or 3-nitropyridylsulfenyl (Npys) group allows the site-specific 
conjugation provided that only one free thiol group is present in the other reaction partner. 
A more stable bond can be obtained by thioether linkages between free thiols with halogen 
compounds or by Michael-type addition of thiols to maleimides [71]. Click chemistry, first 
defined by Sharpless in 2001 [72], is a further approach which amongst other features is 
characterized by  high selectivity, high yields and simple reaction conditions  making it a 
popular tool for the production of precise carriers. It involves different types of conjugation 
strategies, among which the 1,3-dipolar cycloadditon between alkines and azides forming a 
triazole is one of the most commonly used as it can even be performed in living organisms 
[73]. Click chemisty has, for example, been applied to covalently attach targeting ligands to 
siRNA [69, 74], demonstrating its suitability for the synthesis of precise nucleic acid carriers. 
A different attractive linking strategy is the native chemical ligation (NCL), which was 
primarily developed for the conjugation of peptide fragments in protein synthesis [75]. A 
modification of this approach made it applicable to ligate peptide fragments synthesized 
with 9-fluorenylmethoxycarbonyl solid-phase peptide synthesis (Fmoc-SPPS) [76]. This 
conjugation technique has been recently applied in the Wagner lab for the attachment of 
targeting ligands to already existing cysteine-containing sequence-defined carriers for DNA 
and siRNA delivery (Zhang et al, submitted).  
A rather new approach in precise carrier synthesis is to exploit the unique property of 
nucleic acids to self-assemble into defined nanostructures, which can be used as delivery 
devices for nucleic acids [77]. In contrast to natural nucleic acids, artificial DNA structures of 
specific size and shape can be taken up by cells and show much higher stability to nucleases. 
The easy way of cargo loading by direct integration (e.g. the immunostimulatory CpG motif 
[78]) or hybridization of the therapeutic nucleic acid with the DNA nanostructure turn them 
to attractive tools for nucleic acid delivery. Promising results including prolonged blood 
circulation, tumor accumulation and silencing effect in a mouse model after systemic 
application have been achieved using a DNA tetrahedron loaded with siRNA as well as 
several folic acid ligands with controlled density and orientation [79]. These findings support 
the notion that sequence-control at every single position of the carrier and exact 
determination of modification sites play a key role in optimization of carrier design.  
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2.3 Solid-phase assisted synthesis: an approach to design sequence-defined carriers 
-
-carboxy group of another amino acid. After the 
first peptide bond formation between two amino acids by using acyl chlorides in 1903 [80], 
developments of protecting groups and coupling reagents led to the successful synthesis of 
the hormone oxytocin, consisting of nine amino acids, in 1954 [81]. Nevertheless, the 
peptide synthesis with repeated deprotection and coupling steps as well as intercalating 
purifications still constituted a time-consuming procedure of high effort, until Merrifield 
introduced the principle of solid-phase peptide synthesis (SPPS) in 1963 [82]. Here the step 
by step assembled peptide was attached to resin beads consisting of a chloromethylated 
copolymer of styrene and divinylbenzene, which is completely insoluble in the used solvents 
but allows penetration of the reagents. The main benefit of this method is the addition of 
protected amino acids in high excess that shortens reaction times and drives the coupling 
reaction nearly to completion. By filtration in appropriate reactors, unreacted amino acid 
and coupling reagents can be easily removed. After the complete assembly of the desired 
sequence the peptide can be cleaved from the resin in a final step. Even though during the 
first attempt to synthesize a tetrapeptide the great value of the principle became apparent, 
also the need for optimized protocols to avoid side reactions, hazardous reactants or 
solvents and to improve yields and purities of the obtained peptides was recognized. In 
1972, Carpino et al. [83] presented the 9-fluorenylmethoxycarbonyl (Fmoc) as a base-labile 
protection group for the N-terminus of the peptide, which is stable under the reaction 
conditions during SPPS and constitutes orthogonality to acid-labile side chain protection 
groups. It did not gain much attention until the chemical industry became aware of the 
potential provided by this strategy and made the spectrum of easy producible Fmoc-
protected amino acids commercially available. A further advantage is given by the high UV 
absorption of the fluorene derivatives, which enables monitoring of the reaction process and 
facilitates automation of peptide synthesis. Nowadays, the Fmoc strategy is established as 
the standard procedure for SPPS besides the classical tert-butyloxycarbonyl (Boc) strategy. 
Hartmann et al first used the solid-phase synthesis technique for the assembly of defined 
polyaminoamides (PAAs) by alternating coupling steps of diacids, activated as cyclic 
anhydrides, and diamines [84]. For PAAs with five diamine blocks the monodisperse 
chemical structure could be demonstrated and attachment of functional domains resulted in 
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useful DNA complexation systems [85]. Nevertheless, synthesis of longer PAAs bears the 
potential of cross-linking reactions when adding the diamine to the activated carboxylic acid 
residues (Schaffert, PhD thesis, 2010). In this context, Schaffert et al optimized this strategy 
by combining the diacid (succinic acid) and the diamine (tetraethylene pentamine) in one 
building block [61]. Properly protected with the acid-labile Boc protecting group at the 
secondary amines and the base-labile Fmoc group at the primary terminal amine, the 
resulting artificial amino acid Stp(boc)3-OH was used for the synthesis of a wide spectrum of 
sequence-defined carriers for nucleic acid delivery [63, 66-68, 86]. 
Taking advantage of the SPPS strategy, Mixson and coworkers synthesized highly-branched 
peptides consisting of lysine and histidine and demonstrated their potency for DNA [87] and 
siRNA delivery [88]. Also EHCO, an amphiphilic surfactant containing histidine, cysteine and 
oleoyl tails was synthesized by Lu and colleagues by combination of organic synthesis and 
classical peptide bond formation, both performed on solid-phase [89]. Based on this 
lipopeptide further modification by PEG shielding and attachment of the peptide bombesin 
as a targeting ligand resulted in an efficient siRNA delivery system [90]. 
Andaloussi et al exploited the strategy of SPPS for the assembly of PepFect6, which had 
proven to be an efficient siRNA carrier [58]. The synthesis of the CPP transportan-10 (TP-10) 
as well as the subsequent stearylation and attachment of a chloroquine analog were 
performed on solid-phase thereby ensuring the precise structure of this carrier system. 
All mentioned examples emphasize the suitability of SPPS for the synthesis of synthetic 
vectors for nucleic acid delivery and especially the opportunity for rational design due to 
sequence control at every single position of the assembled molecule. In addition, the 
described studies also reveal that not only classic amino acids can be applied, but also a wide 
diversity of functional domains can be incorporated by the means of solid-phase synthesis. 
2.4 Impact of size on gene carrier properties  
Besides remarkable success in the use of lipidic carriers for nucleic acid delivery, cationic 
polymers have gained great attention among the synthetic vectors. Due to its remarkable 
DNA condensation efficiency PLL has been widely used in delivery systems for DNA [91] and 
for siRNA [92]. Normally synthesized by N-carboxy anhydride polymerization, it is 
commercially available in a wide MW range from 500 Da up to over 200 kDa. Testing PLL of 
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different polymerization degrees (4  224 kDa) for DNA binding and transfection efficiency, 
revealed a clear influence of the MW on its properties as a gene carrier [93]. Whereas the 
maximum DNA binding was found for PLL of intermediate MW (24 kDa), a clear increase of 
transfection efficiency was found with increasing MW up to the MW of 53.7 kDa. Also PEI 
became a commonly used DNA delivery agent due to its great efficiency for nucleic acid 
transfection, but cytotoxicity as well as polydispersity are inherent characteristics of the 
polymer that need to be addressed before its safe therapeutical application. By now, 
evidence has emerged indicating that the cytotoxicity of cationic polymers is often 
correlated with their molecular weight (MW), showing greater cytotoxicity with increasing 
MW [94-96]. Therefore several studies have been performed modifying the original PEI 
structure (22 kDa linear or 25 kDa brPEI) aimed at decreasing the cytotoxicity while 
simultaneously maintaining or even increasing the delivery efficiency. These include the 
conjugation of low molecular weight (LMW) PEI via biodegradable linkages [97-103], the 
attachment of LMW PEI to other polymer backbones [104, 105] or the functionalization of 
the amine groups of the native PEI for the purpose of changing its chemical and thus 
biological properties [46, 106-108]. In contrast to consistent data regarding the cytotoxicity 
dependency on MW, for the transfection efficiency contradictory findings were published. 
Whereas Godbey et al found a correlation of higher gene transfer with increasing MW from 
1.8 to 70 kDa [109], Werth et al could isolate a low MW fraction around 4  10 kDa out of 
the 25 kDa brPEI with enhanced efficiency compared to the original polymer [96]. Comparing 
in vivo gene transfer to the brain of 25, 50 and 800 kDa PEI, Abdallah et al identified the 25 
kDa sample as the most potent one [110]. These opposing findings point out the general 
importance of MW for gene transfer activity, but do not allow general conclusions. In order 
to set up precise correlations it must always be considered which specific MW range has 
been analyzed.  
Based on the artificial amino acid succinyl-tetraethylene pentamine (Stp), PEI analogs have 
recently been designed in order to overcome the already mentioned main disadvantages of 
PEI [61]. Both carriers contain the diaminoethane motif responsible for nucleic acid 
complexation and endosomal buffering. Properly protected (Fmoc/tBoc) Stp is applicable to 
standard Fmoc-based SPPS, thus allowing the synthesis of precise, sequence-defined carriers 
[63, 111] and the controlled variation of size. A simple linear sequence of five Stp units was 
found inactive in gene transfer [111]. This was not surprising as the number of only 16 
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protonatable nitrogens was much smaller than the approximately 500 (±200) protonatable 
nitrogens of standard linear PEI (LPEI). Nevertheless, the general knowledge of the size-
dependency of transfection efficiency and the initial finding that increasing the number of 
Stp units improved DNA binding and gene transfer provided the basis for further evaluations 
of the effect of MW on the properties of the described structures in the course of this thesis.  
2.5 Influence of topology on gene carrier properties 
Cationic polymers have gained more and more interest as synthetic carriers for nucleic acid 
delivery. The importance of carrier topology for the purpose of modulating their biophysical 
properties and biological performance has long been recognized. Differences in biophysical 
characteristics and in the transfection efficiency of brPEI and LPEI have been shown in 
several studies [112, 113]. Wightman et al found a much higher aggregation tendency of 
LPEI in salt-containing solution, but a 10- to 100-fold better transfection efficiency compared 
to brPEI under saltfree conditions [112]. Also Kwok et al found better performance of LPEI 
for DNA delivery [113]. However, LPEI was completely inactive for siRNA transfer, whereas 
brPEI displayed considerable knockdown. These findings are explained based on the 
different PEI structures, resulting in differing basicity of incorporated amines determining 
the nucleic acid condensation ability. A study using PAAs with different branched 
architectures reported an improved DNA compaction ability and buffer capacity, and 
therefore enhanced transfection efficiency with increasing degree of branching [114]. 
Further polymeric carriers that have been extensively investigated for DNA and siRNA 
delivery are the hyperbranched PAMAM dendrimers and their modifications [52, 53, 115, 
116]. The change of topology by using a triethanolamine core instead of commonly used 
diamines provides the dendrimer with increased flexibility and high efficiency for siRNA 
delivery [116]. This modification is based on the finding that partially degraded PAMAM 
shows better flexibility and DNA complexation ability [117]. To gain deeper insight into the 
influence of polymer structure on DNA complexation and polyplex morphology, Tang et al 
compared the DNA interaction and polyplex formation of four polycations, namely PLL, 
intact PAMAM dendrimer, fractured PAMAM dendrimer and PEI [118]. According to the 
measured biophysical properties of the carrier and the corresponding particles formed with 
DNA, the authors concluded that the polymer structure and MW are only minor 
determinants of DNA binding ability, particle size and morphology, but the individual type of 
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polymer greatly influences the aggregation tendency. However, the polymer structure 
greatly impacts on the polymer flexibility and buffer capacity, constituting two parameters 
with distinct effect on the transfection efficiency. 
Several studies have investigated the effect of varying the length of oligoamine moieties in 
polymeric carriers on biophysical properties, buffer capacity and especially nucleic acid 
transfection efficiency [68, 119-121].  Significant effects of the number and type of amines 
and total amine density have been demonstrated. Uchida et al -even 
containing even-numbered ethylenamine side chains [120], emphasizing the number of 
protonatable amines in row. The importance of the spacer length between the amino groups 
was revealed by Lin et al showing that the extension of the ethylene unit to propylene 
reduced the transfection efficiency and increased the toxicity [119], pointing out the 
importance of the spacer length between the amino groups. 
More recently, in order to overcome the main disadvantage of cationic polymers, namely 
their polydispersity and significant toxicity as known for PEI [122-124], novel analogs 
containing defined smaller ethylenimine units were designed [98, 99, 101, 102, 125-127]. For 
example, the diaminoethane motif was introduced into the artificial amino acid Stp [61]. This 
motif was found to be effective for nucleic acid binding and endosomal buffering and thus 
provides the basis for the production of precise, sequence-defined carriers [54, 63, 64, 67, 
68, 111, 128]. The importance of carrier topology was once more emphasized by the finding 
that 3-arm and 4-arm branched or differently shaped structures, which vary in the site of 
fatty acid modification, can differ greatly in terms of DNA binding and transfection efficiency 
[63]. Besides structural changes also the use of oligo(aminoethane) building blocks of 
different length was shown to have considerable influence on the DNA binding 
characteristics and the buffering profile [66]. These findings underline the importance of 
investigating structure-activity relationships by variation of structure as well as of total 
number and type of the amine for the optimization of carrier design.  
2.6 Aim of the thesis  
Gene delivery holds great promise for the treatment of several incurable diseases by directly 
addressing the cause of the dysfunction. Major drawbacks result from the fact that nucleic 
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acids, in contrast to many protein- or peptide-based therapies, have their place of action 
inside the cell and for this reason need an appropriate delivery system. 
Based on the prevailing notion that polymer length is a major determinant of carrier efficacy, 
the first aim of this thesis was to investigate the effect of increasing MW on the properties of 
precise cationic carriers for DNA delivery. More specifically, it had to be explored if an 
exclusive enlargement of the carrier size could compensate for the lack of additional 
functional domains, thus eliminating the commonly recognized requirement for stabilization 
motifs or endosomal release helper domains. For this purpose a small library of linear 
oligo(ethanamino)amides of increasing chain length had to be synthesized in order to 
systemically examine the influence of different MWs on biophysical and biological carrier 
properties. The findings of this study should provide fundamental insights for the design of 
sequence-defined oligo(ethanamino)amide carriers. 
With increasing carrier size, conventional methods for analytical characterization as NMR 
and mass spectrometry (MS) reach their threshold of applicability and can be applied 
adequately only with distinct expertise. This limitation determined a further focus of the 
thesis, namely finding suitable methods for the analytical characterization of precise, 
polycationic oligo(ethanamino)amide carriers. Capillary electrophoresis (CE) and Taylor 
dispersion analysis (TDA) were to be tested in a collaboration project for their application for 
the analysis of oligomers of increasing length, both representing methods of great potential 
for the characterization of charged species of a wide range of MW. 
Besides the concept of size regulation, the modulation of functionality and topology 
constitutes a further promising approach to address the overriding objective of carrier 
optimization. In this context, as the second major aim of the thesis, a new comb-like 
topology was introduced and had to be optimized by subsequent application of different 
functionalities to this novel structural class. These functionalities included domains for DNA 
condensation and polyplex stabilization as well as components for modulating the 
endosomal buffering, all aimed at designing efficient carriers for DNA delivery. The final aim 
of the thesis was to work out the specific impact of carrier topology by directly comparing 
the most relevant carrier properties of these new comb-type structures with the 
corresponding linear ones. By this means the influence of changes in topology on relevant 
biophysical and biological features should be elucidated. 
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3 MATERIALS AND METHODS 
3.1 Chemicals and reagents 
Trityl OH-ChemMatrix resin was obtained from Biotage (Uppsala, Sweden). Allyl alcohol, 
N,N-dimethyl-barbituric acid (N,N-DMBA), 1-hydroxybenzotriazol (HOBt), 
tetrakis(triphenylphosphine)-palladium (Pd(Ph3P)4), triisopropylsilane (TIS), Triton X-100, 
hydrazine monohydrate, 2,2,2-trifluoroethanol (TFE), N-ethylmorpholine (NEM), 3-(4,5-
dimethylthiazol-2-yl) - 2,5 - diphenyltetrazolium bromide (MTT), diethylene triamine (DETA), 
triethylene tetramine (TETA), tetraethylene pentamine (TEPA) and pentaethylene hexamine 
(PEHA) were purchased from Sigma-Aldrich (Munich, Germany); benzotriazol-1-yl-oxy-tris-
pyrrolidino-phosphonium hexafluoro-phosphate (PyBOP), 2-(1H-benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HBTU), and microreactors for manual and 
automatic synthesis from MultiSynTech (Witten, Germany). Linear PEI (LPEI, 22kDa average 
MW) was synthesized as described previously [129]. Fmoc-PEG24-OH was obtained from 
Quanta biodesign (Powell, Ohio, USA) and trifluoroacetyl pteroic acid from Niels Clauson-
Kaas A/S (Farum, Denmark). All other amino acids, peptide grade dimethylformamide (DMF), 
peptide grade N-methylpyrrolidone (NMP), diisopropyl-ethylamine (DIPEA) and 
trifluoroacetic acid (TFA) were purchased from Iris Biotech (Marktredwitz, Germany). 
Sephadex G-10 material for size exclusion chromatography was obtained from GE Healthcare 
(Freiburg, Germany). GelRed was purchased from Biotum Inc. (Hayward, USA). Cell culture 
media, antibiotics and fetal calf serum (FCS) were purchased from Invitrogen (Karlsruhe, 
Germany). Plasmid pCMVLuc was produced with the Qiagen Plasmid Giga Kit (Qiagen, 
Hilden, Germany) according to the manufacturer protocol. Cy5-labeling kit for pDNA labeling 
was obtained from Mirus Bio (Madison, WI, USA). Luciferase cell culture lysis buffer and D-
luciferin sodium salt were obtained from Promega (Mannheim, Germany). CellTiter-
Glo®Reagent was purchased from Promega (USA). Solvents and all small molecule reagents 
were bought in high quality from Sigma-Aldrich (Steinheim, Germany), Iris Biotech 
(Marktredwitz, Germany), AppliChem (Darmstadt, Germany) or Merck (Darmstadt, 
Germany), unless otherwise indicated. Water was used as purified, deionized water. 
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3.2 Solid-phase assisted peptide synthesis  general procedures 
3.2.1 Automated peptide synthesis 
The automated microwave peptide synthesis was performed on the Syrowave® system from 
Biotage AB (Uppsala, Sweden) applying the standard Fmoc/tBu protecting group strategy. 
Exact synthesis procedure is described in the sections 3.3 and 3.4. As solid support a 2-
Chlorotrityl Chloride resin or Trityl-ChemMatrix resin was used. All structures were 
synthesized in a 7 to 15 µmol scale using a 2 mL or 5 mL syringe reactor. For automated 
synthesis the resin was pre-swollen for 20 min in NMP and for manual synthesis in DCM.  
3.2.2 Resin loading 
Loading of a Chlorotrityl Chloride resin with Dde-Lys-Fmoc-OH. 0.8 mmol of a chlorotrityl 
chloride resin (516 mg) were pre-swollen in DCM (1 mL/100 mg resin) for 15 min and Dde-
Lys-Fmoc-OH (0.8 eq) and DIPEA (1.6 eq) dissolved in DCM (dried over CaCl2) were added to 
the resin for 3 h. After draining the reaction solvent a mixture of DCM/MeOH/DIPEA 
(80/15/5) was added twice for 15 min. After the removal of the reaction mixture, the resin 
was washed 5 times with DCM (1 mL/100 mg resin). Some resin was separated for 
determination of the resin loading and the remaining resin was treated 3 times for 5, 10 and 
20 min with 20 % piperidine in DMF for removal of the N -Fmoc protection group. 
Deprotection was checked by a positive Kaiser test. Afterwards, the resin was washed 3 
times with DMF and DCM and dried in vacuum.  
Loading of a Chlorotrityl Chloride resin with Fmoc-Cys-Trt-OH. 0.8 mmol of a chlorotrityl 
chloride resin (516 mg) were pre-swollen in DCM (1 mL/100 mg resin) for 15 min. Fmoc-Cys-
Trt-OH (0.4 eq) and DIPEA (0.8 eq) were dissolved in DCM (dried over CaCl2) and added to 
the resin for 45 min to obtain a low loaded resin of 0.1 to 0.3 mmol/g. Subsequent steps 
were performed as described above for the loading of a chlorotrityl chloride resin with Dde-
Lys-Fmoc-OH. 
Loading of ChemMatrix-Trityl resin. 0.5 g ChemMatrix-Trityl-OH resin (0.2 mmol) were 
swollen in 3.3 mL DCM (1 mL/100 mg resin, dried over CaCl2). 67 µL SOCl2 were added to get 
a final concentration of 2 % SOCl2 in DCM. The vessel was shaken over night. Then the resin 
was drained and rinsed with DCM (5 x 3 ml) and 2 % N-ethyl morpholine (NEM) in DCM (3 x 3 
ml). Afterwards Fmoc-Cys(Trt) (0.6 mmol, 3 eq) and NEM (4 eq) dissolved in DCM were 
Materials and Methods  22 
added and the vessel was shaken over night. After addition of 167 µL of a solution of 25 % 
NEM in methanol and shaking for 1 h the resin was drained and rinsed 3 times each with 3 
mL DCM, DMF, methanol and diethyl ether. The resin was dried over night at room 
temperature. Some resin was separated for determination of the resin loading. 
Loading of a Chlorotrityl Chloride resin with Fmoc-Stp-(boc)3-OH. 0.8 mmol of a chlorotrityl 
chloride resin (516 mg) were pre-swollen in DCM (1 mL/100 mg resin) for 15 min and Fmoc-
Stp-(boc)3-OH (0.8 eq) and DIPEA (1.6 eq) dissolved in DCM (dried over CaCl2) were added to 
the resin for 2.5 h. After draining the reaction solvent a mixture of DCM/MeOH/DIPEA 
(80/15/5) was added twice for 15 min. After the removal of the reaction mixture, the resin 
was washed 5 times with DCM (1 mL/100 mg resin). Some resin was separated for 
determination of the resin loading and the remaining resin was treated 3 times for 5, 10 and 
20 min with 20 % piperidine in DMF to remove the N -Fmoc protection group. Deprotection 
was checked by a positive Kaiser test. Afterwards, the resin was washed 3 times with DMF 
and DCM and dried in vacuum. 
Loading of a Chlorotrityl Chloride resin with Fmoc- -Ala-OH. 0.8 mmol of a chlorotrityl 
chloride resin (516 mg) were pre-swollen in DCM (1 mL/100 mg resin) for 15 min. Fmoc- -
Ala-OH (0.4 eq) and DIPEA (0.8 eq) were dissolved in DCM (dried over CaCl2) and added to 
the resin for 45 min. All subsequent steps were performed as described above for the 
loading of a chlorotrityl chloride resin with Fmoc-Stp-(boc)3-OH. 
3.2.3 Determination of the resin loading  Fmoc quantification 
For determination of the resin loading about 10 mg of the resin were separated from the 
main batch and dried under vacuum. An exact amount of resin was then treated with 1 mL 
deprotection solution (20 % piperidine in DMF) for 1 h, diluted in DMF and UV absorption 
was measured at 301 nm. Finally, the resin loading in [mmol/ g] is obtained by the following 
equation:  
resin load [mmol/g] = (A*1000) / (m [mg]*7800*df) with df as dilution factor. 
3.2.4 Kaiser test 
Kaiser test was used for qualitative detection of free amino groups on the resin. For this 
purpose a small amount of resin beads, previously washed 3 times with DMF and 3 times 
with DCM, were transferred to an Eppendorf tube. One drop of each 80 % (w/v) phenol in 
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EtOH, 5 % (w/v) ninhydrin in EtOH and a solution of 0.02 mM KCN in pyridine were added to 
the resin and the tube heated for 4 min at 99 °C. In the absence of free amino groups the 
beads remained colorless and the solution yellow (negative Kaiser Test). The presence of 
free amino groups was indicated by a blue coloration of the resin beads and the solution 
(positive Kaiser test). 
3.2.5 Synthesis of diaminoethane motif-containing building blocks 
The cationic building blocks Stp(boc)3-Fmoc and Sph(boc)4-Fmoc were synthesized as 
described in [61] and [68], respectively. Briefly, the synthesis is based on selective protection 
of the primary amines of TEPA (for Stp(boc)3-Fmoc) or PEHA (for Sph(boc)4-Fmoc) with ethyl 
trifluoroacetate and subsequent Boc-protection of the secondary amines with di-tert butyl 
dicarbonate. Deprotection of the primary amines is done with NaOH. Assymetrical 
functionalization of one amine group with Fmoc-Osu and the other one with succinic 
anhydride results in the desired products that are purified with dry column vaccum 
chromatography (DCVC). 
Synthesis of Boc-protected building block Stp(boc)4-OH 5 
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Synthesis of tfa-tetraboc-TEPA 3 
Tetraethylenepentamine hydrochloride (TEPA*HCl) (1) (22.58 g, 100 mmol, 1 eq, technical 
grade) was dissolved in 400 mL dry MeOH. Following addition of TEA (50.6 g, 5 eq) the 
mixture was stirred for 2 h and cooled down to -78 °C. Ethyl trifluoroacetate (14.2 g, 100 
mmol, 1 eq) was diluted in 50 mL dry MeOH and added dropwise to the cooled mixture over 
45 min. The temperature was then increased to 0 °C and the reaction mixture was stirred for 
1 h. Without intermediate purification step, the remaining amines were protected by di-tert 
butyl dicarbonate. Therefore, first TEA (50.6 g, 500 mmol, 1.25 eq/amine) was added and 
stirred at 0 °C for 20 min. In the next step di-tert-butyl dicarbonate (109.07 g, 500 mmol, 
1.25 eq/amine) was dissolved in 200 ml dry MeOH and added dropwise over 60 min at 0 °C. 
The mixture was stirred over night. 
The organic phase was concentrated to remove MeOH and the residue was dissolved in 
DCM. It was washed 3 times with 100 mL of a saturated NaHCO3 solution and then 3 times 
with H2O. The organic phase was dried over Na2SO4 anhydrous and the solvent was 
evaporated to obtain a yellowish viscous liquid. 
The yellow, oily residue was recrystallized from a minimum amount of about 30 mL boiling 
DCM under reflux. For this purpose precooled n-hexane was added slowly to the boiling 
DCM till clouding was observed at the drop-in site. The crystallization solution was stored 
over night at 4 °C. The microcrystalline residue was filtered, washed 3 times with cooled n-
hexane and dried. Yield 37.4 g (54.5 mmol, 54.5 %). 1H NMR (400 MHz, CDCl3):  1.42 (s, 36H 
CH3 ter-But), 3.3-3.45 (m, 16H, -CH2- Tepa) ppm. 
Synthesis of tetraboc-TEPA 4 
To a suspension of compound 3 (34.25 g, 50 mmol) in EtOH (380 mL) a 3 M aqueous NaOH 
solution (175 mL) was slowly added under stirring and the reaction mixture was heated up to 
40-50 °C until the solution was clear. The reaction mixture was stirred over night. The EtOH 
was evaporated and the aqueous phase was extracted 3 times with 150 mL DCM. The 
organic phase was dried over NaSO4 and the solvent was evaporated, yielding an amorphous 
solid which was dried under high vacuum and stored at 4 °C. Purification was performed by 
DCVC (DCM/ MEOH; 10:0 to 7:3 v/v).  
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Yield: 11 g (18.7 mmol, 37, 3 %). 1H NMR (400 MHz, CDCl3 CH3 ter-But), 3.3-
3.45 (m, 16H, -CH2- Tepa) ppm. 
Synthesis of Stp(boc)4-OH 5 
To a solution of compound 4 (11 g, 18.7 mmol, 1 eq) in THF (200 mL) TEA (2.81 g, 28.05 
mmol, 1.5 eq) was added followed by dropwise addition of succinic anhydride (2.24 g, 22.44 
mmol, 1.2 eq) in THF (50mL) at room temperature over 30 min and overnight stirring. H2O 
(200 mL) was then added to the mixture and stirred for 1 h before THF was subsequently 
evaporated completely under vacuum. For purification H2O (100 mL) and an aqueous 
solution of NaHSO4 (5 % w/v, 200 mL) were added to the reaction mixture and extracted 
with pure DCM (4 x 80 mL). The organic phase was dried with Na2SO4, the solvent was 
concentrated and dried in high vacuum to get a white solid, which was directly used for 
solid-phase peptide synthesis. 
Yield: 11 g (15.95 mmol, 85, 3 %). 1H NMR (400 MHz, CDCl3 CH3 ter-But), 
2.45-2.65 (m, 4H, -CH2- succ), 3.3-3.45 (m, 16H, -CH2- Tepa) ppm. 
Synthesis of Boc-protected building blocks Sdt(boc)2-OH and Stt(boc)3-OH 
The building blocks were synthesized in analogy to the protocol for Stp(boc)4-OH, but using 
DETA (for Sdt(boc)2-OH synthesis) and TETA (for Stt(boc)3-OH synthesis) instead of TEPA. 
(Sdt(boc)2-OH and Stt(boc)3-OH were synthesized by Dr. Naresh Badgujar (LMU, postdoctoral 
fellow). 
Synthesis of Boc-protected building block Sph(boc)5-OH 
Sph(boc)5-OH was synthesized in analogy to the protocol for Stp(boc)4-OH with some 
modifications described in the following. For purification pentaethylene hexamine (PEHA, 
technical grade) was first converted into the hydrochloride salt. For this 40 mL PEHA were 
dissolved in 180 mL MeOH and cooled in an ice-bath. Concentrated HCl was added dropwise 
while stirring and a precipitate formed after the addition of about 60 mL. This was filtered, 
washed with acetone and ether and dried in vacuum. Tfa-pentaboc PEHA was synthesized in 
analogy to the protocol for tfa-tetraboc-TEPA. In the following step, to a suspension of tfa-
pentaboc PEHA (24.87 g, 30 mmol) in EtOH (400 mL) and 50 mL DCM, a 3 M aqueous NaOH 
solution (175 mL) was slowly added under stirring and the reaction mixture was heated up to 
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50-60 °C until the solution was clear. The reaction mixture was further stirred over night, the 
solvent was evaporated and the aqueous phase was extracted 3 times with 200 mL DCM. 
The organic phase was dried over NaSO4 and the solvent was evaporated, yielding an 
amorphous solid which was dried under high vacuum and stored at 4 °C. Purification was 
performed by DCVC (DCM/ MEOH; 10:0 to 7:3 v/v).  
Yield: 11 g (18.7 mmol, 37, 3 %). 1H NMR (400 MHz, CDCl3 CH3 ter-But), 3.3-
3.45 (m, 20H, -CH2- Peha) ppm. 
3.3 Synthesis of linear (ethanamino)amide oligomers 
Two different strategies were initially tested for the oligomer synthesis, namely the 
successive coupling of single Stp units or the stepwise attachment of blocks of 5 Stp units in 
a convergent manner. The convergent strategy was initially used with the aim of saving time 
during the assembly of long sequences, but at room temperature inefficient couplings were 
found to occur. The subsequent application of microwave irradiation during coupling and 
deprotection steps however demonstrated the suitability of both methods under these 
conditions. Using the later established automated synthesis strategy with successive 
couplings was less time-consuming and therefore preferentially used. 
3.3.1 Oligomer assembly with successive couplings 
The oligomers were assembled on a ChemMatrix-Trityl-Fmoc-Trp(boc) resin with a loading 
between 0.2 and 0.3 mmol/g pre-swollen in NMP for 20 min. Until cycle 10 N -Fmoc 
deprotection was performed 3 min at 50 °C with 40 % piperidine in DMF, followed by 3 min 
with 20 % piperidine in DMF at 60°C and 10 min at 50°C. Amino acids (4 eq, 0.2  0.5 M) 
were dissolved in HOBt (4 eq) in NMP, DIPEA (8 eq) was dissolved in NMP and HBTU (4 eq) 
was dissolved in DMF. Single couplings were performed from cycle 1 to 10 for 8 min at 75 °C. 
From cycle 11 on double couplings were performed for 6 minutes at 75 °C. Fmoc-
deprotection was performed as described above for the previous cycles but with an 
additional deprotection step for 5 min at 50 °C with 20 % piperidine in DMF. After each 
deprotection as well as each coupling step the resin was washed 5 times with DMF.  
Cleavage of oligomers from the resin 
Cleavage from the resin was performed by treatment with a cleavage solution containing 
TFA/TIS/H2O (95/2.5/2.5) for 1.5 h. After washing the resin twice with TFA and twice with 
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DCM all solutions were combined, concentrated and precipitated by dropwise addition into 
a mixture of n-hexane and MTBE (1:1) cooled to -20 °C. The pellet after centrifugation was 
dried under nitrogen and dissolved in the buffer for size exclusion containing 10 mM HCl and 
30 % ACN. After purification by size exclusion on a G-10 column the appropriate fractions 
were combined, frozen in liquid nitrogen and lyophilized. 
3.3.2 Oligomer assembly via convergent coupling strategy 
Convergent synthesis of Fmoc-[Stp(boc)3]5-OH and Fmoc-[Stp(boc)3]5- -Ala-OH 
After swelling 500 mg of a Fmoc-Stp(boc)3-OH chlorotrityl resin (loading 0.35 mmol/g) in 
DCM for 20 min, Fmoc-Stp(boc)3-OH (3 eq) and DIPEA (6 eq) dissolved in DCM and 
PyBOP/HOBt (3 eq) dissolved in DMF were added for 2 h. The reaction solvent was drained 
and the resin was washed 3 times with DMF and DCM. If necessary, the coupling was 
repeated with 2 eq of Fmoc-Stp(boc)3-OH until Kaiser test was negative. For removal of the 
Fmoc protecting group, the resin was treated with 20 % piperidine in DMF 3 times for 10 min 
and complete deprotection was monitored with a positive Kaiser test. After washing the 
resin with DMF and DCM the same procedure was repeated 3 times without Fmoc 
deprotection after the last coupling step. Indicating a negative Kaiser test, the resin was 
washed 5 times with DCM and dried in vacuum. 
For the synthesis of Fmoc-[Stp(boc)3]5- -Ala-OH a Fmoc- -Ala-OH chlorotrityl resin (loading 
0.35 mmol/g) was used and the coupling of Fmoc-Stp(boc)3-OH was repeated 5 times as 
described above. 
Cleavage of the convergent building blocks from the resin 
A mixture of 30 % TFE in DCM (1 mL/80 mg resin) was added to the resin and replaced every 
30 to 60 min. The reaction progress was monitored by TLC with a mobile phase of 
CHCl3/MeOH (9/1) containing 1 % HOAc. Cleavage was finished when no absorption was 
detected on a thin layer chromatography plate anymore. All cleavage solutions were 
collected, the solvent evaporated and dried under vacuum. 
Synthesis of [Stp5]8-W with convergent building blocks 
30 mg of the ChemMatrix resin loaded with Fmoc-Trp(boc)-OH (0.262 mmol/g) were pre-
swollen in NMP. Subsequently, the convergent building block Fmoc-Stp(boc3)5-OH (4 eq) and 
DIPEA (8 eq) dissolved in a minimum amount of NMP, and HBTU/HOBt (4 eq) dissolved in a 
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minimum amount of DMF were added for  8 min for the first 4 couplings at 75 °C.  For the 
last 4 couplings the coupling time was elongated to 10 min. Reaction progress was 
monitored by Kaiser test. For Fmoc deprotection the resin was treated twice with a solution 
of 20 % piperidine in DMF for 4 min at 60 °C and again monitored by Kaiser test. After the 
third coupling Fmoc deprotection was performed by several treatments of 5 min with a 
solution containing 20 % piperidine, 2 % DBU and 1 % Triton X-100 in DMF until the UV 
absorption at 301 nm of the deprotection solution was below 0.1.  
Synthesis of [Stp5- 6-W with convergent building blocks 
To 25 mg of the pre-swollen ChemMatrix resin loaded with Fmoc-Trp(boc)-OH (0.22 mmol/g) 
the convergent building block Fmoc-[Stp(boc)3]5- -Ala-OH (2 eq) and DIPEA (4 eq) dissolved 
in NMP and HBTU/HOBt (2 eq) dissolved in DMF were added for  45 min at 60 °C. For Fmoc 
deprotection the resin was treated twice (4 min and 20 min) with a solution of 20 % 
piperidine in DMF at 50 °C. 
3.4 Synthesis of comb structure oligomers 
Two different strategies, a convergent manual and an automated synthesis were 
established. Suitability of both methods was demonstrated (Figure 19), but the less time-
consuming automated synthesis was preferentially used.  
3.4.1 Comb structures synthesis with convergent coupling strategy 
Convergent synthesis of Fmoc-Lys-Stp(boc)4 
After swelling 0.15-0.2 mmol of a Dde-Lys-OH chlorotrityl resin in DCM for 20 min, Stp(boc)4-
OH (4 eq) and DIPEA (8 eq) dissolved in DCM and PyBOP/HOBt (4 eq) dissolved in DMF were 
added for 90 min. The reaction solvent was drained and the resin was washed 3 times with 
DMF and DCM. If necessary, the coupling was repeated until Kaiser test was negative. For 
removal of the N -Dde protection group, the resin was treated with 2 % hydrazine in DMF for 
5 min and the procedure was repeated until the UV absorption of the deprotection solution 
measured at 290 nm was below 0.1. After washing the resin with DMF and DCM, Fmoc-Cl (6 
eq) and DIPEA (12 eq) in DCM were added twice for 30 min. After a negative Kaiser test, the 
resin was washed 5 times with DCM and dried in vacuum. 
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Convergent synthesis of Fmoc-Ala-Lys-[Stp(boc)4]-OH 
After swelling 0.15-0.2 mmol of a Dde-Lys-OH chlorotrityl resin in DCM for 20 min, Stp(boc)4-
OH (4 eq) and DIPEA (8 eq) dissolved in DCM and PyBOP/HOBt (4 eq) dissolved in DMF were 
added for 90 min. The reaction solvent was drained and the resin was washed 3 times with 
DMF and DCM. If necessary, the coupling was repeated until Kaiser test was negative. For 
removal of the N -Dde protection group, the resin was treated with 2 % hydrazine in DMF for 
5 min and repeated until the UV absorption of the deprotection solution measured at 301 
nm was below 0.1. After washing the resin with DMF and DCM, Fmoc-Ala-OH (4 eq) and 
DIPEA (8 eq) dissolved in DCM and PyBOP/HOBt (4 eq) dissolved in DMF were added for 90 
min. After a negative Kaiser test, the resin was washed 5 times with DCM and dried in 
vacuum. 
Convergent synthesis of Fmoc-His(boc)-Lys-[Stp(boc)4]-OH 
The synthesis was performed analogously to the synthesis of Fmoc-Ala-Lys-[Stp(boc)4]-OH 
using Fmoc-His(boc)-OH instead of Fmoc-Ala-OH. 
Cleavage of the convergent building blocks from the resin 
A mixture of 30 % TFE in DCM (1 mL/80 mg resin) was added to the resin and replaced every 
30 to 60 min. The reaction progress was monitored by TLC with a mobile phase of 
CHCl3/MeOH (9/1) containing 1 % HOAc. Cleavage was finished when no UV absorption was 
detected on a thin layer chromatography plate anymore. All cleavage solutions were 
collected, the solvent evaporated and dried under vacuum. 
Comb structure assembly with convergent building blocks 
To the pre-swollen resin loaded with Cys-Trt-OH the convergent building block (4 eq) and 
DIPEA (8 eq) dissolved in a minimum amount of DCM and PyBOP/HOBt (4 eq) dissolved in a 
minimum amount of DMF were added for 90 min and the reaction progress was monitored 
by Kaiser test. The coupling was repeated with new reagents until the Kaiser test was 
negative. For N -Fmoc deprotection the resin was treated with a solution containing 20 % 
piperidine, 2 % DBU and 1 % Triton X-100 in DMF for 5 to 30 min and repeated until the UV 
absorption at 301 nm of the deprotection solution was below 0.1. The coupling and 
deprotection procedure were repeated 8 times and in the final coupling step Boc-Cys-Trt 
was used instead of the convergent building block. 
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3.4.2 Comb structures via backbone assembly and subsequent  
The automated microwave peptide synthesis was performed on the Syrowave® system from 
Biotage AB (Uppsala, Sweden). The backbone was assembled on a ChemMatrix-Trityl-Fmoc-
Cys-Trt resin with a loading of around 0.28 mmol/g pre-swollen in NMP for 20 min. N -Fmoc 
deprotection was performed at 50 °C, twice for 3 min with 40 % piperidine in DMF, followed 
by 5 and 10 min with 20 % piperidine in DMF. Amino acids (4 eq, 0.23 M) were dissolved in 
0.23 M HOBt in NMP, DIPEA (8 eq) was dissolved in NMP and HBTU (4 eq) was dissolved in 
DMF. Double couplings were performed for 8 minutes at 75 °C. After each deprotection and 
coupling step the resin was washed 3 times with DMF. For backbone assembly Fmoc-Lys-
Dde-OH was used as well as Boc-Cys-Trt in the last coupling step. For the backbones 
containing a spacer amino acid, Fmoc-Ala-OH or Fmoc-His-Trt-OH was coupled after every 
lysine. After the backbone assembly the Dde-protecting group was removed by washing the 
resin with 2 % hydrazine in DMF for 5 min and the UV absorbance of the cleavage solution 
was checked at 290 nm. The washing was repeated until the value of absorbance was below 
0.1. 
Cleavage of oligomers from the resin 
To cleave the oligomers from the resin, the latter was treated with a cleavage solution 
containing TFA/TIS/H2O (95/2.5/2.5) for 1.5 h. Afterwards the resin was washed twice with 
TFA and twice with DCM. All the solutions were combined, concentrated and precipitated by 
dropwise addition into a mixture of n-hexane and MTBE (1:1) cooled to -20 °C. The pellet 
after centrifugation was dried under nitrogen and dissolved in the buffer for size exclusion 
consisting of 10 mM HCl and 30 % acetonitrile. After purification by size exclusion on a G-10 
column the product containing fractions were combined, frozen in liquid nitrogen and 
lyophilized. 
3.4.3 Synthesis of a targeted comb structure by the use of the Dde-Alloc orthogonality 
The synthesis of C-K(PEG24-FolA)-[H-K(Stp)]8-C was performed as described in section 3.4.2 
with the following modifications. For the backbone assembly Fmoc-Lys-Alloc-OH was used 
before the last coupling of the terminal Boc-Cys-Trt-OH. The Dde cleavage was performed 
with 10 % hydrazine in DMF in the presence of 200 eq of allyl alcohol per Alloc protection 
group as described in [130]. The comb attachment was done as described in the previous 
section. In the next step the cleavage of the Alloc group was performed as described in 
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[131]. Briefly, Pd(Ph3P)4 (0.1 eq per Alloc group) and N,N-DMBA (5 eq per Alloc group) were 
flushed under argon, protected against light and dissolved together in DCM for 4 min. The 
mixture was transferred to the reaction vessel and stirred for 2 h under argon. The whole 
procedure was repeated up to 4 times until the positive Kaiser test indicated complete 
removal of the Alloc protection group. Finally, the resin was washed 3 times with DCM, 5 
times with 0.2 M DIPEA in DMF and 6 times with DMF. Next, Fmoc-PEG24-OH (4 eq) was 
double-coupled for 30 min at RT and 8 min at 70 °C. Fmoc deprotection was then performed 
5 min at 50 °C and repeated several times until the UV absorption of the piperidine solution 
at 301 nm was below 0.1. Fmoc-Glu-OtBu was coupled according to the protocol of the 
backbone assembly (3.4.2). Trifluoroacetyl pteroic acid was attached as described for the 
PEG coupling. In the last step, before the cleavage of the peptide from the resin according to 
the standard procedure, the trifluoroacetyl group was removed by treating four times for 30 
min with a 50 % (v/v) solution of 1 M aqueous NH3 solution and DMF. 
3.4.4 Synthesis of linear control sequences 
The automated microwave peptide synthesis was performed on the Syrowave® system 
(Biotage AB). The sequences were assembled on a ChemMatrix-Trityl-Fmoc-Cys-Trt resin 
with a loading of around 0.28 mmol/g pre-swollen in NMP for 20 min. N -Fmoc deprotection 
was performed twice for 3 min at 50 °C with 40 % piperidine in DMF, followed by 5 and 10 
min with 20 % piperidine in DMF. Amino acids (4 eq, 0.23 M) were dissolved in 0.23 M HOBt 
in NMP, DIPEA (8 eq) was dissolved in NMP and HBTU (4 eq) was dissolved in DMF. Double 
couplings were performed for 8 min at 75 °C. After each deprotection and after each 
coupling step the resin was washed 3 times with DMF. For backbone assembly Fmoc-Lys-
Boc-OH was used alternating with the spacer amino acids Fmoc-Ala-OH or Fmoc-His(Trt)-OH 
as well as Boc-Cys-Trt in the last coupling step. Cleavage was performed as described above 
for the comb oligomers (3.4.2). 
3.5 Oligomer purification and analytical characterization 
3.5.1 Size exclusion chromatography 
Size exclusion chromatography (SEC) was performed with an Äkta Basic HPLC system (GE 
Healthcare, Freiburg, Germany) using a Sephadex G-10 column (60 cm) and 10 mM HCl 
containing 30 % ACN as eluent at a flow rate of 2 mL/min. Olgiomers were detected by UV 
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absorbance at wavelengths of 214, 220 and 280 nm. All product-containing fractions were 
combined and lyophilized. 
3.5.2 1H-NMR spectroscopy 
1H-NMR spectra were recorded using a Jeol JNMR-GX 400 (400 MHz) or JNMR-GX 500 (500 
MHz) device. Chemical shifts are reported in ppm and refer to the solvent as internal 
standard. Data are reported as s= singulet, d= doublet, t= triplet, m= multiplet; integration 
was done manually. Spectra were analyzed using MestreNova by MestReLab Research. 
3.5.3 Mass spectrometry 
MALDI-TOF-MS was carried out on a Bruker Daltonics Autoflex II system using a saturated 
solution of 2,5-dihydroxy benzoic acid (2,5-DHB) in a 1:1 mixture of H2O/ACN with 0.1% TFA 
as a matrix.  
3.5.4 Analytical reversed phase HPLC 
Analytical reversed phase HPLC (RP-HPLC) was performed using a Waters HPLC System 
containing a P-900 gradient pump system under the control of the Millenium software and a 
Waters SunFire C18 (4.6 x 150 mm) column. The gradient was run from 5 % to 100 % buffer B 
at a flow rate of 1mL/min in 20 min with buffer A containing H2O with 0.1 % TFA and buffer B 
Photodiode array detector. 
3.5.5 Buffer capacity  pH titrations 
The oligomer sample, containing 15 µmol protonatable amines, was diluted in a total volume 
of 3.5 mL NaCl solution (50 mM) and the pH was adjusted to 2.1 by addition of 0.1 M HCl. 
Afterwards, a back titration with 0.05 M NaOH solution was performed with an automatic 
titration system (Titrando 905 from Metrohm, Germany) until pH of 11 was reached. 
Furthermore a titration with 50 mM NaCl was performed and the consumption of NaOH in 
this control titration was substracted from the consumption in the oligomer titrations at the 
corresponding pH values. Percentage of buffer capacity C in a certain pH range (x  y), where 
according to equation (1). 
 (1) 
Materials and Methods  33 
3.5.6 Capillary electrophoresis 
Capillary electrophoresis (CE) was performed by our collaboration partners in the laboratory 
of Prof. Hervé Cottet in Montpellier, France. CE analysis was carried out on a P/ACE MDQ CE 
system (Beckman, Fullerton, CA, USA). Hydroxypropylcellulose (HPC) coated capillary of 40.6 
cm 
Prior injection, the capillary was rinsed with water for 10 min and then with the background 
electrolyte for 5 min. Temperature of the capillary cartridge was set at 25 °C. Samples were 
diluted in H2O and injected hydrodynamically at the inlet end of the capillary (20 mbar, 4 s). 
A voltage of +30 kV was applied and data were collected using the Beckman System Gold 
software at 214 nm. As background electrolyte either 10 mM HEPES (pH 7.4), 250 mM HOAc 
-aminocaproic acid (pH 5.7) were used. Electropherograms were 
plotted in electrophoretic mobility scale (P(µep) vs. µep or Abs(214nm) vs. µep) using the 
following equations: 
    (2)
 
 
 (3)
 
 
where µep is the effective mobility, l is the effective capillary length to the detection point, L 
is the total capillary length, V is the applied voltage, tm is the migration time of the solute, 
Abs(tm) is the absorbance at 214 nm, C is a normalization constant (such as the total peak 
area equals one unit). HPC capillary coating: fused silica capillary (Composite Metal Services, 
 in diameter) 
was filled with the polymer solution using a syringe pump at 0.03 mL/h. A stream of N2 gas at 
3 bar was used to remove the excess of HPC solution and maintained during the 
immobilization process of the HPC performed by heating the capillary in a GC oven (GE-14A, 
Shimadzu, France). Temperature program was: 60 °C for 10 min followed by a temperature 
ramp from 60 to 140 °C at 5 °C/min and finally, 140 °C for 20 min. 
3.5.7 Taylor dispersion analysis 
Taylor dispersion analysis (TDA) was performed by our collaboration partners in the 
laboratory of Prof. Hervé Cottet in Montpellier, France. TDA was carried out on a P/ACE 
MDQ CE system (Beckman, Fullerton, CA, USA). UV detection was performed at 214 nm. Rh 
of all samples were determined in various eluents, namely HBG, HCl, NaCl, H3PO4, HOAc and 
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2) 
(equation 4) is obtained by integration of the elution profile. With this parameter the 
molecular diffusion coefficient (D) (equation 5) and the hydrodynamic radius (Rh) (equation 
6) can be calculated as follows: 
    (4) 
     (5) 
   (6) 
In this context, hi is the detector response, td the average elution time at peak apex, Rc the 
capillary radius (in meter), kB the Boltzmann constant, T the absolute temperature (in Kelvin) 
and  the viscosity of the eluent. Uncoated fused silica capillaries were purchased from 
Composite Metal Services (Worcester, UK) with dimensions of 40.6 cm total length (30.3 cm 
 
For PDADMAC coated capillaries, coating was achieved by the following steps. The capillary 
was flushed with 1 M NaOH for 30 min, water for 15 min, 0.2 % PDADMAC solution in water 
for 30 min and finally with water for 15 min. Between the experimental runs, the capillaries 
were purged with water for 3 min followed by 5 min rinsing with the eluent. The coating of 
capillaries with HPC is described in the method section capillary electrophoresis (3.5.6). 
All samples were diluted in the eluent and injected hydrodynamically (35 mbar, 4 s). Under 
these conditions, the ratio of the injected volume to the capillary volume up to the detector 
did not exceed 1 %.  Mobilization pressure of 50 mbar was applied with eluent vials at both 
ends of the capillary. The temperature of the capillary cartridge was set at 25 °C. Data were 
collected using the Beckman System Gold software.  
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3.6 Biophysical analyses 
3.6.1 Polyplex formation 
Polyplexes were prepared by dissolving 200 ng of pDNA and oligomers at indicated nitrogen/ 
phosphate (N/P) ratios each in a total volume of 10 µL HBG buffer. The polycation solution 
was added to the nucleic acid, rapidly mixed and incubated for 30-40 min at RT. 
3.6.2 Agarose gel shift assay  pDNA binding 
For pDNA gel shift assay, a 1 % agarose gel was prepared by dissolving 1.2 g agarose in 120 g 
TBE buffer (trizma base 10.8 g, boric acid 5.5 g, disodium EDTA 0.75 g, in 1 L of water) and 
heating up to 100 °C. After addition of 120 µl GelRed (1000 x) for the detection of the nucleic 
acid, the agarose solution was poured into the electrophoresis chamber. Polyplexes were 
prepared as described in section 3.6.1. To each sample 4 L of loading buffer (prepared from 
6 mL of glycerine, 1.2 mL of 0.5 M EDTA, 2.8 mL of H2O, 0.02 g of bromophenol blue) were 
added before loading into the gel sample pockets. Electrophoresis was performed at 120 V 
for 80 min. 
3.6.3 Ethidium bromide assay  pDNA condensation 
DNA condensation ability was tested using the ethidium bromide (EtBr) assay. The effect of 
stepwise addition of polymer solution to 10 µg pDNA in 1 mL HBG containing 0.4 µg EtBr was 
measured at increasing N/P ratios using a Cary Eclipse spectrophotometer (Varian, Germany) 
at exitation wavelength of 510 nm and emission at 590 nm. Maximal fluorescence intensity 
was set to 100 % for the EtBr solution containing free nucleic acid and fluorescence decrease 
was measured 0.5 min after each addition of polymer aliquot.  
3.6.4 Dynamic light scattering  particle size and zeta potential 
Particle size and zeta potential of polyplexes were measured by dynamic laser-light 
scattering (DLS) using a Zetasizer Nano ZS (Malvern Instruments, Worcestershire, U.K.). 5 µg 
of pDNA were used for polyplex formation in 500 µL HEPES pH 7.4. Before measurement 400 
µL HEPES were added. Measurements were performed as triplicates. 
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3.7 Biological evaluation 
3.7.1 Cell culture 
Cell culture experiments were performed in our laboratory by Petra Kos (PhD student, LMU). 
(DMEM), supplemented with 10 % FCS, 4 mM stable glutamine, 100 U/mL penicillin, and 100 
µg/mL streptomycin, at 37 °C in humidified atmosphere containing 5 % CO2 in air. 
Human cervic carcinoma cells KB were grown in folate free RPMI-1640 medium, 
supplemented with 10 % FCS, 4 mM stable glutamine, 100 U/mL penicillin, and 100 µg/mL 
streptomycin, at 37 °C in humidified atmosphere containing 5 % CO2 in air. 
3.7.2 Flow cytometry  cellular association and internalization 
Flow cytometry was performed by Petra Kos (PhD student, LMU). Neuro2A cells were 
seeded into 24-well plates coated with collagen at a density of 50,000 cells per well. After 
24 
-labeled) 
were added to each well and incubated either at 37 °C for internalization, or at 0 °C for 
association studies, both for 1 and 4 h. All experiments were performed in triplicates. 
Subsequently, only for measurement of internalization, polyplexes adhering on the cell 
surface were removed by washing the cells for 15 min with 500 µL PBS, containing 1000 I.U. 
of heparin. Cells were detached with trypsin/EDTA and taken up in PBS with 10 % FCS. 
Cellular uptake was assayed by excitation of Cy5 at 635 nm and detection of emission at 
665 nm. Cells were appropriately gated by forward/sideward scatter and pulse width for 
exclusion of doublets. DAPI (4',6-diamidino-2-phenylindole) was used to discriminate 
analyzed by FlowJo® 7.6.5 flow cytometric analysis software. 
3.7.3 Luciferase assay  gene transfer 
Luciferase assays were performed by Petra Kos (PhD student, LMU). Neuro2A cells were 
seeded in 96-well plates 24 h prior to transfection using 10,000 cells per well. Polyplexes 
were formed in 20 µL HBG with 200 ng luciferase-encoding pCMVLuc plasmid per well and 
the calculated amount of polymer corresponding to the N/P ratio. All experiments were 
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medium containing 10 % FCS. 24 h after transfection, cells we
buffer (25 mM Tris, pH 7.8, 2 mM EDTA, 2 mM DTT, 10 % glycerol, 1 % Triton X-100). 
Luciferase Assay buffer, Promega, Mannheim, Germany) and a Lumat LB9507 luminometer 
(Berthold, Bad Wildbad, Germany). 
3.7.4 MTT assay  metabolic activity 
MTT assays were performed by Petra Kos (PhD student, LMU). Neuro2A cells were seeded 
into 96-well plates at a density of 10,000 cells per well. After 24 h, culture medium was 
at different N/P ratios were added. All experiments were performed in quintuplicates. 24 h 
after transfection, 10 µL of MTT (5 mg/mL) were added to each well reaching a final 
concentration of 0.5 mg MTT/mL. After an incubation time of 2 h, unreacted dye and 
medium were removed. Optical absorbance was determined at 590 nm (reference 
wavelength 630 nm) using a micro plate reader (Spectrafluor Plus, Tecan Austria GmbH). 
3.7.5 CellTiter-Glo® assay  metabolic activity 
CellTiter-Glo®assays were performed by Petra Kos (PhD student, LMU). Neuro2A cells (5,000 
per well) were seeded in 96-well plates. After 24h, medium was removed and replaced by 
fresh medium containing LPEI or the different Stp oligomers at increasing concentrations 
from 0.01 up to 1.0 mg/mL. All experiments were performed in triplicates. After 48h 
incubation, half of the medium was replaced by CellTiter-Glo®Reagent. The luminescent 
signal, which is proportional to the amount of ATP, was measured with a Lumat LB9507 
luminometer (Berthold, Bad Wildbad, Germany). The luminescent signal of untreated cells 
was taken as the 100 % value to determine the relative metabolic activity of the oligomer 
treated cells. 
3.8 Statistics 
Results are presented as mean ± standard deviation (SD). The number of replicates is 
indicated in the corresponding methods section. 
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4 RESULTS 
Among the synthetic carriers, PEI due to its high efficiency is regarded as the common 
standard reagent for pDNA transfection. The diaminoethane motif provides the polymer 
with positive charges at physiological pH and results in a strong binding ability of the 
negatively charged DNA. Furthermore this motif provides the polymer with a high buffer 
capacity in the pH range between 6 and 7.4, which results in the so-
for the good binding and transfection properties, but due to the high amount of positive 
charges and lack of biodegradability also contributes to the cytotoxic effect. This toxicity as a 
main drawback together with its polydispersity impedes the clinical application and points 
out the need of carrier optimization. The demerit of polydispersity could successfully be 
overcome by the application of solid-phase synthesis for the assembly of gene carriers. In 
SPPS, which was first described by Merrifield in 1963 [82], a peptide is elongated step by 
step on a solid support offering the opportunity to produce sequence-defined structures 
(Scheme 1). Adding a high excess of the reagents, which can easily be removed in following 
washing steps, brings the advantage of fast and efficient coupling steps. The outlined 
principle of peptide synthesis on solid-phase was applied here using a variety of natural and 
artificial amino acids (Figure 1). 
 
Scheme 1. Principle of solid-phase peptide synthesis showing resin loading, alternating deprotection 
and coupling steps and the final acidic cleavage from the resin. AA = amino acid 
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Figure 1. a) Structures of protected diaminoethane building blocks of which Stp(boc)3-OH and 
Sph(boc)3-OH were used in the MW study and the additional ones in the study of the comb topology. 
b) Structures of the used protected natural amino acids. c) Structures of the used protecting groups. 
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 The artificial amino acid succinyl-tetraethylene pentamine (Fmoc-Stp(boc3)-OH) was first 
developed by David Schaffert (PhD thesis LMU, 2010) with the aim of making the 
diaminoethane motif applicable to SPPS [61]. For this purpose the secondary amines of 
tetraethylene pentamine are protected with Boc, an acid-labile amine protecting group, and 
one terminal primary amine is protected with Fmoc, a base-labile amine protecting group, 
while to the other terminal amine a succinyl residue is attached. The latter provides the 
building block with a carboxylic linker enabling the coupling to free amino groups on the 
solid support. After incorporation in the peptide and cleavage of the side chain protecting 
groups, one Stp building block provides three protonatable amines enabling nucleic acid 
complexation and endosomal buffering. The Stp building block as well as the Sph building 
block, providing one additional ethylenamine unit, were used in the study of the length 
effect of linear oligo(ethanamino)amides carriers (section 4.1). 
To assess the impact of variation of topology, a further focus of the conducted study 
(sections 4.3 and 4.4), branching points constitute an essential tool. Branching points can be 
introduced by the incorporation of lysine providing two primary amines. Using two 
-N -N amino 
group, allows performing the previously described backbone elongation in a defined 
sequential manner. By alternating amino acid coupling and Fmoc deprotection with 
-N amino groups after the Dde 
deprotection, branched peptides were synthesized for systematic evaluation of topological 
effects. In addition to lysine, other natural amino acids were used in order to obtain specific 
carrier properties (see section 4.3.2).  
4.1 Evaluation of linear oligo(ethanamino)amide carriers of increasing molecular weight 
for pDNA delivery and comparison to linear PEI 
4.1.1 Carrier design and synthesis 
Previous studies have demonstrated the suitability of the artificial amino acid Stp to produce 
sequence-defined carriers for gene delivery via solid-phase assisted synthesis [63, 66, 67, 
86]. Here a small library of linear oligo(ethanamino)amides without additional functional 
domains was generated in order to investigate specifically the length effect on gene carrier 
properties. Linear oligomers consisting of 5, 10, 15, 20, 30 and 40 Stp units were synthesized 
(Table 1). Furthermore a terminal tryptophane was attached at the C-terminus to facilitate 
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analytical characterization. A 30 Stp units long oligomer with terminal cysteine modification 
was synthesized to investigate if polyplex stabilization via disulfide formation, as observed in 
previous studies [63, 132], was beneficial also for these longer sequences. Furthermore, Stp 
was replaced with the Sph building block, which provides one ethylenamine unit more than 
Stp, in order to investigate whether a similar strong enhancement of DNA transfection 
efficiency could be obtained with Sph as observed in four-arm structures in a previous study 
[68]. The exact structures of all oligomers used in this study are displayed in Scheme 2. 
Compound Id Sequence Molecular weight [Da] Protonatable amines 
681 Stp5-W 1561,02 16 
643 Stp10-W 2917,82 31 
644 Stp15-W 4274,61 46 
645 Stp20-W 5650,56 61 
554 Stp30-W 8345,0 91 
555 Stp40-W 11058,59 121 
556 [Stp5- 6-W 8876,51 91 
682 C-Stp30-W-C 8551,29 91 
683 Sph20-W 6492,77 81 
684 Sph30-W 9637,04 121 
Table 1. Sequences of all oligomer structures written from N- to C-terminus and the corresponding 
MWs. 
 
Scheme 2. Overview of all chemical structures used in this study. a) (Stp)5-40-W, b) C-Stp30-W-C, c) 
[(Stp)5- A]6-W, d) (Sph)20,30-W 
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When standard SPPS at room temperature either on a Wang resin or a Tentagel trityl resin 
was used in initial experiments, oligomers of more than 20 Stp units were obtained only in 
low yield and showing deletion sequences (Figure 2 a). These unsatisfactory results were 
obtained using either a consecutive or convergent coupling strategy. For the convergent 
strategy protected blocks of five Stp units were applied in order to reduce the number of 
couplings and thus saving time. Optimizing the syntheses by using a ChemMatrix resin and 
microwave irradiation for coupling and deprotection led to purer products in a shorter 
period of time (Figure 2 b). Both, the convergent and consecutive coupling strategy were 
suitable with the optimized method. As the consecutive method was less time-consuming 
with the automated synthesis this procedure was maintained for the assembly of all 
structures in this study. Chromatograms of the analytical HPLC of LPEI and the two longest 
oligomers Stp30-W are shown in Figure 3. 
 
 Figure 2. Analytical HPLC of the oligomer [Stp5-ßA]6-W synthesized a) manually and b) with 
automated synthesis. HPLC was performed on a RP SunFire C 18 column using a gradient from 5 % to 
100 % buffer B at a flow rate of 1mL/min in 20 min with buffer A containing H2O with 0.1 % TFA and 
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Figure 3. Chromatograms of analytical HPLC runs of a) LPEI, b) Stp30-W and c) Stp40-W. HPLC was 
performed on a RP SunFire C 18 column using a gradient from 5 % to 100 % buffer B at a flow rate of 
1mL/min in 20 min with buffer A containing H2O with 0.1 % TFA and buffer B containing ACN with 0.1 
 
4.1.2 Biophysical characterization: DNA condensation, particle size and buffer capacity 
Testing the pDNA binding characteristics revealed that an increasing number of Stp units 
improved the polyplex stability. Stp5-W was not able to form stable polyplexes even at N/P 
ratio of 24, Stp10-W showed partial DNA binding from N/P 12 to 24, Stp15-W showed 
complete binding at N/P 18 and higher, whereas all polymers with 20 or more Stp units 
exhibited complete DNA binding already at N/P 12 and partial binding at N/P 6 and 3 (Figure 
4). A cysteine-containing oligomer C-Stp30-W-C showed similar good binding characteristics 
in the gel shift assay as the unmodified Stp30-W (Figure S4 a,b). Also a dissociation assay 
with the anionic polymer heparine resulted in polyplex disassembly at all tested heparine 
concentrations for both the unmodified and cysteine-modified oligomer (Figure 5 a,b). The 
improvement of DNA condensation ability through oligomer elongation becomes also clear 
in the EtBr exclusion assay were the decrease in fluorescence, resulting from higher EtBr 
exclusion by polyplex formation after oligomer addition, increases with increasing MW of 
the oligomers (Figure 6). LPEI still displays a higher DNA condensation ability compared to 
the best-performing Stp oligomer. 
Substituting the Stp building block for Sph in the oligomers with 20 and 30 units provided 
one additional ethylenamine unit without significantly changing the binding characteristics 
(Figure 4). -
alanine was incorporated into the Stp30-W oligomer after every fifth Stp unit. Decreased 
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DNA binding ability was observed (Figure 4). Continuous improvement was clearly seen with 
increasing N/P ratio, but even the highest tested N/P ratios of 18 and 24 did not display 
complete binding. 
 
Figure 4. pDNA binding ability of linear Stp and Sph oligomers of increasing molecular weight 
determined by agarose gel shift assay at increasing N/P ratios as indicated. Last panel: effect of 
varied charge density by incorporation of -alanine. 
 
Figure 5 . Polyplex dissociaton analysis using the DNA agarose gel shift assay. Upper panels:  Stp30-W 
and C-Stp30-W-C at different N/P ratios. Lower panels: Dissocation of polyplexes in the agarose gel 
shift assay at N/P 12 of Stp30-W and C-Stp30-W-C treated with 0.1 I.E. heparine (lane 1),  0.2 I.E. 
heparine (lane 2),  0.4 I.E. heparine (lane 3),  TCEP (lane 4) and  0.2 I.E. heparine + TCEP (lane 5).  
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Figure 6. pDNA binding capacity of LPEI and linear Stp oligomers. EtBr exclusion assays with 
increasing N/P ratios obtained by stepwise addition of the oligomer to pDNA solution at pH 7.4. 100% 
value displays fluorescence intensity of DNA and EtBr before the addition of the polymer. 
Determination of particle sizes measured by DLS indicated that with increasing number of 
Stp units the particle size decreased (Table 2). With a size over 1 µm, Stp5-W was the only 
polymer not able to form compact polyplexes with pDNA. For the oligomer with 10 Stp units 
a particle size of around 300 nm was observed, for 15 Stp units 140 nm and for 20 Stp units 
and more the measured particle sizes had values around 100 nm and were therefore similar 
to LPEI polyplexes with 130 nm. Also the cysteine-modified sequence C-Stp30-W-C and the 
Sph-containing sequences Sph20-W and Sph30-W formed DNA polyplexes around 100 nm, 
confirming the similar complexation characteristics observed in the gel shift assay. In 
comparison to Stp30-W, for polyplexes formed using the analo -alanine 
slightly larger complex sizes were detected. For all polyplexes a positive zeta potential 
around 20 mV was measured, except for Stp5-W in consequence of the absence of 
nanosized particles (Table 2). 
Next, the buffer capacity of Stp and Sph oligomers was determined in the biological pH range 
of 5.0 to 7.4 in order to investigate the influence of increasing MW and building block type. 
This interest arose based on the odd-even rule established by Kataoka et al for N-substituted 
polyaspartamides, stating that diaminoethylene substituents containing an even number of 
protonatable amines provided higher buffer capacity and gene transfer activity than odd-
numbered substituents [120]. Accordingly, in the Wagner lab Sph oligomers (4 protonatable 
amines in row) were found to show higher buffer capacities than Stp oligomers (3 
protonatable amines in row) [66]. In the present work, Stp and Sph oligomers of increasing 
MW displayed similar buffer capacities between 15 and 20 % independent of type and 
Results  46 
number of the used building block (Figure 7), also in the same range as LPEI. This observation 
suggests that the odd-even rule only applies to oligomers below a certain size-threshold. 
 Z-average [nm] PDI Zeta potential [mV] 
LPEI 129,0 ± 2,8 0, 310 26,0 ± 1,2 
Stp5-W 1720,7 ± 62,9 0,549 3,2 ± 0,3 
Stp10-W 331,1 ± 11,8 0,272 18,7 ± 0,3 
Stp15-W 143,8 ± 5,5 0,294 20,2 ± 0,6 
Stp20-W 103,5 ± 4,2 0,286 20,5 ± 0,8 
Stp30-W 98,0 ± 8,6 0,31 19,4 ± 1,9 
Stp40-W 118,4 ± 3,4 0,279 20,6 ± 1,0 
C-Stp30-W-C 87,1 ± 0,9 0, 164 24,6 ± 0,5 
[Stp5- 6-W 127,7 ± 1,2 0, 251 20,4 ± 0,3 
Sph20-W 86,4 ± 8,6 0,353 24,4 ± 4,1 
Sph30-W 70,5 ± 0,6 0,278 26,9 ± 1,6 
Table 2. Particle size (indicated as Z-average), polydispersity index (PDI) and zeta potential of all 
oligomer/pDNA complexes at N/P 12 measured by DLS. 
 
Figure 7. Buffer capacity of Stp and Sph oligomers and LPEI measured in the pH range of 5.0 and 7.4. 
4.1.3 Biological evaluation: Cellular internalization, gene transfer and cytotoxicity 
Cellular uptake studies performed to investigate the influence of the carrier length revealed 
that a certain minimum length of the oligomer is necessary for successful internalization of 
the polyplexes (Figure 8). Accordingly, particles formed with Stp5-W showed a rather weak 
uptake, which was already remarkably enhanced for the Stp10-W polyplexes and further 
improved for Stp15-W (Figure 8 a). Particles formed with oligomers containing more Stp 
units (20 to 40) all showed similar high internalization properties (Figure 8 b). Substituting 
the Stp building block for the Sph building block did not change the extent of internalization 
Results  47 
(Figure 8 c). Also the cysteine modification did not alter the uptake compared to the 
unmodified Stp30-W (Figure 8). 
 
 
Figure 8. Cellular internalization of Cy5-labeled DNA/oligomer complexes at N/P 12 determined by 
flow cytometry in Neuro2A cells after 4 h at 37 °C. a) Stp5-W = red, Stp10-W = dark blue, Stp15-W = 
light green; b) Stp20-W = orange, Stp30-W = dark green, Stp40-W = light blue; c) Stp20-W = orange, 
Stp30-W = green, Sph20-W = orange dotted, Sph30-W = green dotted; d) Stp30-W = green, C-Stp30-
W-C = purple. X-
with according fluorescence signal after appropriate gating. All incubations were performed in 
standard serum-supplemented culture medium. In the internalization studies, cells were washed for 
15 min with heparin to remove polyplexes on the cell surface (see Materials and Methods). The 
experiments were performed by Petra Kos (PhD thesis LMU, 2014). 
The influence of the oligomer MW on transfection efficiency was examined by luciferase 
pDNA gene transfer to Neuro2A neuroblastoma cells (Figure 9). Whereas the smallest Stp 
oligomer Stp5-W was completely inactive, increasing the number of Stp units led to a 
continuously improving gene transfer. Stp15-W at its highest N/P ratio 24 already exceeded 
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the activity of LPEI at its optimum, non-toxic concentration (N/P 6). Stp30-W displayed the 
highest transfection efficiency of all tested oligomers, outnumbering LPEI 6-fold. An 
additional elongation to 40 Stp units could not further improve pDNA delivery. Altogether 
the results nicely demonstrate a positive impact of increasing MW on transfection efficiency. 
For the best-performing oligomer Stp30-W a cysteine-modified analog was synthesized, 
which led to comparable high luciferase expression levels (Figure 10). Also exchanging the 
Stp building block to Sph, which in previous studies significantly improved gene transfer 
activity of four-arm oligomers [68], could not further increase the transfection efficiency 
(Figure 10). However, a Stp30- -alanine incorporation after every fifth Stp 
unit resulted in a clear decrease of gene transfer activity (Figure 10). 
 
Figure 9. Luciferase gene transfer by LPEI and linear Stp oligomers tested with pCMVLuc pDNA in 
Neuro2A cells at N/P ratios 6, 12 and 24. The experiment was performed by Petra Kos (PhD thesis 
LMU, 2014). 
 
Figure 10. Luciferase gene transfer by LPEI and linear Stp and Sph oligomers tested with pCMVLuc 
pDNA in Neuro2A cells at N/P ratios 6, 12 and 24. The experiment was performed by Petra Kos (PhD 
thesis LMU, 2014). 
As additional biological characteristic we next determined the cytotoxicity of the different 
oligomers by the MTT and CellTiter-Glo® assay. None of the polyplexes formed with 
oligomers or LPEI at optimum N/P ratios showed any significant cytotoxicity detectable by 
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the MTT assay which measures the mitochondrial redox state as a quantification of cell 
viability (Figure 11). When the oligomers were tested as free oligomers at increasing 
concentrations in the CellTiter-Glo® assay measuring intracellular ATP levels, considerable 
differences in cytotoxicity were observed (Figure 12). For cells treated with LPEI already at a 
concentration of 0.2 mg/mL metabolic activity was lost, whereas for Stp40-W, the most toxic 
of the linear Stp oligomers, still 90 % residual metabolic activity could be observed at a 
concentration of 0.4 mg/mL. For the Stp oligomers, toxicity levels were very low; 
nevertheless a clear increase of toxicity was detected with increasing MW. While Stp5-W did 
not show any toxicity at any examined concentration, all oligomers with 20 or more Stp units 
displayed a reduced metabolic activity (below 20 %) at the highest tested concentration of 
1.0 mg/mL. It has to be emphasized that oligomer concentrations as used in optimum 
transfection experiments are around 10 µg/mL. 
 
Figure 11. Metabolic activity determined with the MTT assay in Neuro2A cells of LPEI (N/P 6) and all 
linear Stp and Sph oligomers. The experiment was performed by Petra Kos (PhD thesis LMU, 2014). 
 
Figure 12. Metabolic activity of Neuro2A cells treated with increasing LPEI or oligomer 
concentrations determined by CellTiter-Glo® assay. For untreated cells 100 % metabolic acitivity was 
defined and all other values refer to this value. The experiment was performed by Petra Kos (PhD 
thesis LMU, 2014). 
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4.2 Analytical characterization of oligo(ethanamino)amides by capillary electrophoresis 
and Taylor dispersion analysis 
4.2.1 Determination of the effective mobility of oligo(ethanamino)amides of different 
length by capillary electrophoresis 
Determination of the electrophoretic mobility is of high interest in order to gain information 
about the charge, the size and the hydrodynamic behavior of charged species. Therefore we 
started a collaboration project with the lab of Dr. Laurent Leclercq and Prof. Dr. Hervé 
Cottet, U. Montpellier. Electrophoretic techniques, such as capillary electrophoresis (CE), 
constitute a useful tool for the determination of the effective mobility and for the separation 
of oligomers and polymers. CE is a separation procedure performed in a silica-filled capillary 
tube of a diameter around 50 µm. The instrumental arrangement is shown in Figure 17. 
Separation efficiency is generally controlled by longitudinal diffusion. This explains the 
extraordinary high resolution for macromolecules with low diffusion coefficient and its 
extensive application for analytical characterization of a large variety of small molecules, 
oligomers or polymers. The simplest separation principle using CE is the so-called capillary 
zone electrophoresis (CZE), where the sample is injected as a narrow band dissolved in the 
separation buffer. Each species migrates with its own velocity after application of an electric 
field resulting in separation of the sample components. The electrophoretic mobility µep is 
proportional to the charge of the ion and inversely proportional to the friction coefficient. 
Consequently, in theory, a larger hydrodynamic radius results in a lower electrophoretic 
mobility for a given charge. 
Here, CZE was applied to four representative oligomers of the library, namely Stp10-W, 
Stp20-W, Stp30-W and Stp40-W, to investigate the effect of increasing MW on the 
electrophoretic mobility. At low pH value of 2.7 (in 250 mM HOAc) all oligomers showed a 
high mobility, as it was expected due to the high degree of protonation at this pH (Figure 
13).  
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Figure 13. Electropherograms showing the electrophoretic mobility of the oligomers Stp10-W, Stp20-
W, Stp30-W and Stp40-W recorded in 250 mM acetic acid at pH 2.70. Applied voltage was 30 kV. Y-
axis displays UV absorbance at 214 nm. The experiment was performed by Xiaoyun Jin (PhD student) 
and Dr. Laurent Leclercq from the laboratory of H. Cottet, U. Montpellier. 
Quit -aminocaproic acid. As 
the pH value around 5.7 was much higher and therefore the cationic charge lower, 
decreased electrophoretic mobility was found (Figure 14). Stp10-W shows individual small 
peaks at lower mobilites, likely corresponding to the lower molar masses. For such small 
oligomers, the electrophoretic mobility increases with the molar mass. For larger oligomers 
(20, 30 and 40 Stp units), the mobility decreases with increasing number of Stp units. A 
further increase of the pH value to 7.4 using 10 mM HEPES as electrolyte results in 
conversion of the migration order compared to that obtained at lower pH values (Figure 15), 
likely due to specific effects of the buffer constituents. 
 
Figure 14. Electropherograms of the oligomers Stp10-W, Stp20-W, Stp30-W and Stp40-W recorded in 
-aminocaproic acid at pH 5.70. Applied voltage was 30 kV. Y-axis displays UV absorbance at 
214 nm. The experiment was performed by Xiaoyun Jin (PhD student) and Dr. Laurent Leclercq from 
the laboratory of H. Cottet, U. Montpellier. 
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Figure 15. Electropherograms of the oligomers Stp10-W, Stp20-W, Stp30-W and Stp40-W recorded in 
10mM HEPES at pH 7.4. Applied voltage was 30 kV. Diagram is plotted in the electrophoretic mobility 
scale (P(µep) vs. µep). The experiment was performed by Xiaoyun Jin (PhD student) and Dr. Laurent 
Leclercq from the laboratory of H. Cottet, U. Montpellier. 
In order to obtain size-dependent separation, capillary gel electrophoresis (CGE), which 
means performing CE in a gel network, was applied to the oligomers by addition of 5 % 
dextran solution (500 kDa) to the background electrolyte. In theory, the molecular sieve 
effect of the formed dextran gel should allow faster migration of small molecules and 
retardation of large molecules. The resulting electropherograms show a clear decrease in the 
electrophoretic mobility due to the gel network hindering migration (Figure 16). 
Furthermore, peak broadening can be observed as the migration through the gel provides a 
higher MW-dependent selectivity in the oligomer velocity. To improve the resolution of the 
separation a higher dextran concentration of 10 % was applied, but probable interactions of 
the dextran polymer with the oligomers did not lead to reliable results (data not shown).  
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Figure 16. CGE electropherograms of the oligomers Stp10-W, Stp20-W, Stp30-W and Stp40-W 
recorded in 250 mM acetic acid at pH 2.7. Curve 1 shows the electropherogram in the presence of 
5% dextran and curve 2 the electropherogram without dextran. Applied voltage was 10 kV. Y-axis 
displays UV absorbance at 214 nm. The experiment was performed by Xiaoyun Jin (PhD student) and 
Dr. Laurent Leclercq from the laboratory of H. Cottet, U. Montpellier. 
4.2.2 Determination of the hydrodynamic radius Rh of oligo(ethanamino)amides of 
different length by Taylor dispersion analysis 
The instrument used for CE can also be used to perform Taylor dispersion analysis (TDA) 
(Figure 17). TDA is an absolute method for the determination of the hydrodynamic radius Rh 
based on the dispersion of a sample plug in a laminar flow. The dispersion (over the tube 
cross section) results from the overlay of two phenomena: the dispersive velocity profile as a 
consequence of the laminar flow generated by a small pressure drop between the two 
capillary ends, and the molecular diffusion that redistributes the molecules in the capillary. 
The Taylor dispersion 2) obtained by 
integration of the elution profile. This is recorded via measurement of the UV absorption of 
an UV active solute [133]. With the help of the temporal variance the molecular diffusion 
coefficient (D) and hydrodynamic radius (Rh) can be calculated without any calibration 
(absolute determination, see equations in the methods section 3.5.7). 
In comparison to the commonly used size determination by DLS or SEC, TDA provides several 
advantages. The fact that it constitutes an absolute method for the size determination 
overcomes the need for complex calibration procedures. It can measure molecular sizes 
from angstrom to hundreds of nm, which is a great advantage for the characterization of 
nanomaterials. Moreover, it is considered more meaningful than the Z-average that is 
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derived from DLS measurements since it leads to a weight-averaged particle diameter when 
using weight sensitive detectors (which is the case for the UV absorbing oligomers of this 
work). In the case of bimodal samples, deconvolution of the recorded taylorgram allows the 
determination and quantification of each single population of the sample [134]. As an 
experimental procedure consuming sample volumes of only a few nanoliters, it is applicable 
to a wide spectrum of molecules, which might be available only in small quantities due to 
cost intensive, time-consuming or sophisticated production. TDA has already been used for 
the characterization of small molecules and polymers [133], but also for peptides, proteins 
and liposomes [135, 136]. 
 
Figure 17. Capillary electrophoresis instrument and principle of Taylor dispersion analysis. For the 
Taylor dispersion analysis only pressure (no voltage) is applied. 
Correlation of molecular weight and hydrodynamic radius 
Here, TDA was applied to investigate the correlation of the hydrodynamic radius Rh and the 
oligomer length by analyzing four representative sequences containing 10, 20, 30 or 40 Stp 
units. Figure 18 illustrates a typical example of a taylorgram, displaying the time-dependent 
elution profile of the oligomer, detected by UV absorption. Table 3 displays the average Rh 
values obtained by TDA of the four tested oligomers in two different electrolytes. As 
expected, an increase of the hydrodynamic radius from 0.96 nm up to 1.94 nm with 
increasing oligomer length can be observed for the oligomers ranging from 10 to 30 Stp 
Results  55 
units. However, a decreased Rh value was detected for the longest oligomer, Stp40-W. A 
further interesting observation was the appearance of two populations of different Rh for 
Stp20-W in both elution buffers and for all other oligomers only in HEPES buffer. Except for 
Stp-10-W, where the large population made up a ratio of 35 % and the smaller population 
65%, for all other oligomers the percentages of species with higher and lower Rh value are 
approximately similar.  
 
Figure 18. Exemplary Taylorgram of Stp30-W recorded in a PDADMAC coated capillary with HBG pH 
7.4 as eluent. Deconvolution allows the detection of two populations with different Rh (Rh1 = 0.55 nm 
(w % = 75), Rh2 = 1.48 nm (w % = 25), Rhav = 0.78 nm). The experiment was performed by Xiaoyun Jin 
(PhD student) and Dr. Laurent Leclercq from the laboratory of H. Cottet, U. Montpellier. 
 
Rh average [nm] 
in 10 mM HEPES 
pH 7,30 
Rh of 2 populations 
Rh [nm] average 
in 250 mM HOAc 
pH 2,68 
Rh of 2 
populations 
Stp10-W 0.96 
1.65 (35 %) 
0.61 (65 %) 
0.87 - 
Stp20-W 1.31 
2.19 (45 %) 
0.54 (55 %) 
1.31 
1.90 (50 %) 
0.68 (50 %) 
Stp30-W 1.94 
2.64 (60 %) 
0.91 (40%) 
1.93 - 
Stp40-W 1.24 
2.19 (45 %) 
0.51 (55 %) 
1.18 - 
Table 3. Hydrodynamic radius Rh of the oligomers Stp10-W, Stp20-W, Stp30-W and Sp40-W 
determined in 10 mM HEPES (pH 7.30) or 250 mM HOAc (pH 2.68) by Taylor dispersion analysis. The 
experiment was performed by Xiaoyun Jin (PhD student) and Dr. Laurent Leclercq from the 
laboratory of H. Cottet, U. Montpellier. 
Effect of pH value and buffer on hydrodynamic radius Rh 
The detected Rh of 0.78 nm of the oligomer Stp30-W (MW 8345.0) in HBG buffer appears 
quite small in comparison to the value of 0.25 nm determined for the small molecule 
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caffeine (MW 194.2). Based on the assumption that a high amount of glucose might disturb 
the measurement, the TDA experiment performed in pure HEPES buffer resulted in a Rh of 
1.94 nm and was therefore more than two-fold higher than in glucose-containing buffer 
(Table 4). TDA experiments with the same oligomer, Stp30-W, in different buffer systems of 
decreasing pH, revealed a simultaneous increase of the hydrodynamic radius up to 3.06 nm 
in 50 mM HCl. 
 HEPES (20mM) 
Glucose (280 mM) 
HEPES 
(10 mM) 
HOAc 
(250 mM) 
HCl 
(10 mM) 
HCl 
(50 mM) 
pH 7.4 7.3 2.68 2.04 1.38 
Rh average 
[nm] 
0.78 1.94 1.93 2.61 3.06 
Rh of 2 
populations 
1.48 (25 %) 
0.55 (75 %) 
2.64 (60 %) 
0.91 (40 %) 
- 
3.45 (60 %) 
1.40 (40 %) 
- 
Table 4. Rh values of the oligomer Stp30-W determined in different buffer solutions and pH values by 
TDA. The experiment was performed by Xiaoyun Jin (PhD student) and Dr. Laurent Leclercq from the 
laboratory of H. Cottet, U. Montpellier. 
4.3 Optimization of comb-like oligomers for pDNA delivery 
4.3.1 Design and synthetic strategy 
The solid-phase assisted synthesis of cationic oligomers using the artificial oligoamino acids 
Stp or Sph has been used to establish polymer libraries including effective carriers for gene 
delivery [63, 68, 111]. In these previous studies the artificial amino acids were incorporated 
into the oligomer backbone, resulting in linear structures or structures with up to five arms 
when branching points were introduced. Here the cationic building blocks were attached to 
-N of an oligolysine backbone producing eight comb-like oligoamine branches (Scheme 
3). Because the terminal amines remain free instead of being part of the subsequent amide 
bond as for the linear shaped oligomers, in these comb oligomers each artificial amino acid 
provides one additional protonatable amine. Besides this benefit a distinct change in carrier 
topology is achieved with the new strategy.   
The carrier assembly was performed in two different ways. First, a convergent approach was 
tested, where a building block was assembled, consisting of lysine protected with Fmoc at 
-N amino group and the Boc-protected cationic building block conjugated to the -N 
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amino group (Scheme 3). Coupling these building blocks eight times led to the final comb 
oligomers. 
 
 
Scheme 3. a) Synthesis of the protected building blocks used for the comb structure synthesis with 
the convergent strategy. b)  Structures of the synthesized comb structures. AA = amino acid; exact 
structures are depicted in  
The second synthesis strategy was to assemble the backbone first, using Fmoc-Lys(Dde)-OH. 
In a subsequent step the Dde protection group is cleaved and finally the cationic building 
-N amino groups of the lysines, forming eight branches. 
The convergent coupling strategy at room temperature was quite inefficient due to the large 
size of the building block, which probably led to steric hindrance. After the first three 
coupling steps, the coupling times had to be prolonged tremendously up to 3 h and double 
or triple couplings became necessary. With the aim of solving these problems an automated 
synthesizer was acquired and established for this application. Using this method, double 
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successful synthesis. Analytical data (Figure 19 a-c) and transfection efficiency (Figure 19 d) 
show that both approaches yield suitable products, but as the automated synthesis is much 
less time-consuming, it was preferentially used. 
 
 
 
Figure 19. a) 1H-NMR spectra in D2O of Stp-cmb-0 synthesized with the automatic peptide 
synthesizer. b) 1H-NMR spectra in D2O of Stp-cmb-0 synthesized manually. c) RP-HPLC 
chromatogramm (5 % to 100 % ACN in 20 min) of Stp-cmb-0 synthesized manually and with the 
Results  59 
peptide synthesizer d) Luciferase gene transfer of Stp-cmb-0 synthesized manually (man) and with 
peptide synthesizer (PS) tested with pCMVLuc in Neuro2A cells. Part d) was performed by Petra Kos 
(PhD thesis LMU, 2014). 
Initial studies of comb structures with four repeating lysine units had shown only low pDNA 
transfection efficiency (Figure 20). Increasing the number to eight branches improved the 
biological performance so that this number was chosen for the design of all subsequent 
comb structures. 
 
Figure 20. Comparison of the activity of comb structures with 4 and 8 Stp-modified lysine units in the 
luciferase gene transfer assay tested with pCMVLuc in Neuro2A cells at N/P ratios 6, 12 and 24. The 
experiment was performed by Petra Kos (PhD thesis LMU, 2014). 
4.3.2 -Ala) 
From previous work in the Wagner Lab [63, 132] it is known that terminal cysteines serve as 
useful carrier modifications. The oxidation of thiol groups leads to disulfide formation during 
polyplex formation and stabilizes the complexes via crosslinking. In the present work comb 
oligomers with 8 branches, one carrying terminal cysteines and another one terminal alanine 
residues as a control, were compared. The higher stability (Figure 21) and transfection 
efficiency (Figure 22) confirms the benefit of cysteines also for the comb structures. 
Therefore, the cysteine-modification was maintained in the course of further carrier 
optimization. 
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Figure 21. Comparison of pDNA binding of the cysteine-modified comb structure C-[K(Stp)]8-C and 
the alanine-modified control structure with and without 30 min TCEP incubation after polyplex 
formation at increasing N/P ratios as indicated. 
To vary the distance between the comb branches, different natural amino acids were 
incorporated in the oligolysine backbone (Scheme 3b). Alanine was used to investigate a 
-alanine, which extends the comb backbone by providing 
one methylene unit more - amino acids and might therefore also change 
the 3D structure of the oligomer. Tryptophane was introduced as an example for an 
aromatic, hydrophobic amino acid, which might be beneficial for polyplex stabilization. 
Histidine was incorporated as a spacer amino acid because the imidazole group with a pKA 
value around 6 is known to contribute to the endosomal escape via the proton sponge effect 
during endosome acidification [137]. 
The introduction of an alanine spacer had a slightly positive effect on transfection efficiency 
but did not greatly influence other biophysical and biological properties compared to the 
-
alanine led to decreased transfection efficiency (Figure 22), most likely due to reduced DNA 
complexation ability (Figure 23). The incorporation of tryptophane or histidine both 
enhanced the transfection efficiency. For further detailed investigations of structure-activity 
relationships by the attachment of diaminoethane building blocks of different length (see 
Chapter 4.3.3) and the direct comparison to linear control sequences (see Chapter 4.4) three 
structures were chosen from the comb structure library. All three structures have terminal 
cysteine modifications, one without spacer amino acid (cmb-0), one with alanine spacer 
(cmb-A) and one with histidine spacer (cmb-H). 
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Figure 22.  Luciferase reporter gene expression after transfection using cysteine- or alanine-modified 
Stp comb structures containing different spacer amino acids tested with pCMVLuc pDNA at N/P 12 in 
Neuro2A cells. The experiment was performed by Petra Kos (PhD thesis LMU, 2014). 
 
Figure 23. Comparison of pDNA binding ability of Stp-cmb-0, Stp-cmb-A and Stp-cmb-  comb 
structures determined by EtBr exclusion assay at increasing N/P ratios. 
4.3.3 Application of building blocks with different number of ethylenamine repeating units 
Carrier synthesis and design 
The previously obtained results emphasized the potential for pDNA delivery of a small library 
of comb structure oligomers with the Stp building block. To provide further confirmation and 
gain new insights in structure-activity relationships, three further building blocks, Sdt, Stt, 
and Sph with differing numbers of amino ethylene units were attached to the oligolysine 
backbone, without spacer, with alanine spacer or histidine spacer (Scheme 3b). A list of all 
structures is presented in Table 5. 
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Building block 
Compound 
Id 
Sequence Code 
Protonatable 
amines 
Sdt comb 
(2 prot N) 
632 C-[K(Sdt)]8-C Sdt-cmb-0 17 
633 C-[A-K(Sdt)]8-C Sdt-cmb-A 17 
634 C-[H-K(Sdt)]8-C Sdt-cmb-H 17 
Stt comb 
(3 prot N) 
635 C-[K(Stt)]8-C Stt-cmb-0 25 
636 C-[A-K(Stt)]8-C Stt-cmb-A 25 
637 C-[H-K(Stt)]8-C Stt-cmb-H 25 
Stp comb 
(4 prot N) 
622 C-[K(Stp)]8-C Stp-cmb-0 33 
551 C-[A-K(Stp)]8-C Stp-cmb-A 33 
552 C-[H-K(Stp)]8-C Stp-cmb-H 33 
Sph comb 
(5 prot N) 
629 C-[K(Sph)]8-C Sph-cmb-0 41 
630 C-[A-K(Sph)]8-C Sph-cmb-A 41 
631 C-[H-K(Sph)]8-C Sph-cmb-H 41 
Stp linear 
(3 prot N) 
625 C-(Stp-K)8-C Stp-lin-0 33 
626 C-(A-Stp-K)8-C Stp-lin-A 33 
628 C-(H-Stp-K)8-C Stp-lin-H 33 
Sph linear 
(4 prot N) 
648 C-(Sph-K)8-C Sph-lin-0 41 
649 C-(A-Sph-K)8-C Sph-lin-A 41 
650 C-(H-Sph-K)8-C Sph-lin-H 41 
Table 5. Sequences of comb and linear structures written from N- to C-terminus and the 
corresponding codes used throughout the text. Cmb= comb, lin= linear, 0= no spacer amino acid, A= 
alanine spacer, H= histidine spacer, prot N= number of protonatable nitrogens per building block.  
Biophysical properties 
Testing the pDNA binding characteristics of the comb oligomers with the agarose gel shift 
assay demonstrated complete pDNA complexation ability at N/P ratio of 6 and higher for all 
oligomers with Stt, Stp and Sph building block (Figure 24). The Sdt oligomers with only two 
protonatable amines per comb unit showed the weakest binding which was complete only at 
N/P 12 and higher.  As exception, the histidine containing Sdt structure, showed complete 
binding already at N/P 3. These findings were verified in the EtBr exclusion assay, where the 
Sdt oligomers showed the lowest fluorescence decrease independent of the spacer (Figure 
25). Stt and Sph oligomers compacted the pDNA to a similar extent, while for the Stp 
sequences an enhanced pDNA condensation ability could be observed. This was less 
pronounced for the structures without spacer molecule.  
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Figure 24.  pDNA binding ability of Sdt, Stt, Stp and Sph comb structures determined by agarose gel 
shift assay at increasing N/P ratios as indicated. 
 
Figure 25. EtBr exclusion assay of DNA polyplexes of Sdt, Stt, Stp and Sph comb structures without 
spacer (a), alanine spacer (b) and histidine spacer (c) at increasing N/P ratios. 
Particle sizes measured with DLS greatly differed depending on the length of the 
ethylenamine building block (Table 6). Oligomers consisting of the shortest, less protonated 
building block formed the biggest DNA particles. Sdt oligomers without spacer formed 
aggregates of about 2 µm. Sdt oligomers with Ala and His spacer formed particles of about 
600 and 400 nm, which are still more than 3- and 2- fold bigger than particles formed with 
structures containing the other building blocks of increasing length. With sizes between 170 
and 260 nm also the Stt oligomers produced DNA particles clearly bigger than the Stp and 
Sph oligomers. For Stp oligomers the smallest particles in a range between 100 and 140 nm 
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were observed. They display the highest zeta potential between 27 and 35 mV (Table 6). 
Overall a tendency of decreasing DNA particle size with increasing number of ethylenamine 
units was observed. 
 Z-average [nm] PDI Zeta potential [mV] 
Sdt-cmb-0 2128,7 ± 147,7 0,861 14,5 ± 0,3 
Sdt-cmb-A 607,7 ± 18,7 0,394 17,9 ± 0,2 
Sdt-cmb-H 444,0 ± 35,3 0,353 16,2 ± 0,6 
Stt-cmb-0 175,3 ± 12,9 0,291 10,0 ± 0,8 
Stt-cmb-A 259,3 ± 3,7 0,184 4,2 ± 0,1 
Stt-cmb-H 255,6 ± 23,2 0,277 12,8 ± 1,2 
Stp-cmb-0 136,4 ± 4,0 0,354 27,8 ± 0,1 
Stp-cmb-A 103,6 ± 8,7 0,309 34,2 ± 0,5 
Stp-cmb-H 102,5 ± 9,8 0,319 28,9 ± 0,5 
Sph-cmb-0 109,5 ± 5,4 0,138 26,0 ± 0,1 
Sph-cmb-A 132,3 ± 3,5 0,244 23,8 ± 0,7 
Sph-cmb-H 167,3 ± 17,6 0,371 18,3 ± 1,5 
Table 6. Particle sizes and zeta potential of Sdt, Stt, Stp and Sph comb structure polyplexes with 
pDNA at N/P ratio 12 obtained by DLS measurement.  
The buffer capacity of the oligomers (Figure 26) was measured by alkalimetric titration at the 
pH range between 5.0 and 7.4. This range represents the physiologically relevant 
acidification from pH 7.4 in the extracellular compartment to pH 5.0 in the endosome. Clear 
differences in the buffer capacity could be found for the comb structures with increasing 
number of protonatable amines. The Sdt oligomers with only two protonatable amines per 
branch exhibited by far the highest buffering capacity (Figure 26 a). Stt oligomers with three 
protonatable amines per branches displayed the lowest buffering capacity for the structures 
without spacer and Ala spacer. Increasing the number to four protonatable amines led to an 
increase in the total buffer capacity between 5.0 and 7.4, whereas a further extension to five 
protonatable amines per branch, which can be found in the Sph structures, resulted in a 
small decrease in the buffer capacity. Regardless of the building block, the histidine 
containing oligomers showed the highest total buffer capacity in the pH range between 5.0 
and 7.4.  
On closer examination of the differential buffer capacities in the relevant pH range, two 
different buffering profiles are revealed (Figure 26 b-d). Sdt and Stp containing oligomers 
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with 2 and 4 protonatable amines per branch have the maximum buffer capacity between 
pH 5.5 and 6.5, while Stt and Sph sequences with 3 or 5 protonatable amines in row exhibit 
their maximum capacity between 6.5 and 7.4 (Figure 26 b, c). Only for the histidine 
containing structures discrepancies from this trend are observed. This was predictable due 
to an additive buffering effect of histidine around the pH of 6 (Figure 26 d). 
 
Figure 26.  Buffer capacity of comb-type oligomers. a) Total buffer capacity of Sdt, Stt, Stp and Sph 
comb structures measured in the pH range of 5.0 and 7.4 b)  d) Differential buffer capacities 
between pH 5.0 and 7.4 b) without spacer, c) with Ala spacer and d) with His spacer. 
Cellular uptake and gene transfer 
The cellular uptake of the comb oligomers with different length of ethylenamine building 
blocks was investigated in Neuro2A cells (Figure 27). Polyplexes formed with Stt, Stp and Sph 
oligomers displayed a similar uptake rate independent of the spacer. In the case of the Sdt 
oligomers without spacer the polyplexes were not internalized by the cells. For the Ala- and 
His- containing Sdt structures only a small subpopulation of cells did not internalize any 
particles. The greater fraction of cells showed similar fluorescence intensities as observed for 
the Stt, Stp and Sph oligomers in the flow cytometric analysis. 
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Figure 27. Cellular uptake of Cy5-labeled DNA/oligomer complexes at N/P 12 determined by flow 
cytometry in Neuro2A cells. Comb-shaped oligomers a) without spacer, b) with Ala spacer and c) with 
His spacer; oligomers containing Sdt = green, Stt =  blue, Stp = yellow and Sph = red. X-axis represents 
signal after appropriate gating. The experiment was performed by Petra Kos (PhD thesis LMU, 2014). 
Initial testings of luciferase pDNA transfection efficiency in Neuro2A cells revealed that the 
Stp-containing comb structures modulate the highest gene transfer among the tested 
building blocks (Figure 28). Histidine-containing oligomers displayed the greatest gene 
transfer efficiency in each group. Except for the Stt oligomers, also the Ala spacer resulted in 
a higher gene expression compared to the structures without spacer. The best performing 
sequence, Stp-cmb-H, at the N/P ratio of 6 exceeded LPEI 26-fold at its most effective, non-
toxic concentration (Figure 29).  
 
Figure 28. Luciferase gene transfer of all Sdt, Stt, Stp and Sph comb structures tested with pCMVLuc 
pDNA in Neuro2A cells. The experiment was performed by Petra Kos (PhD thesis LMU, 2014). 
a) b) c) 
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Figure 29. Comparison of luciferase gene transfer of linear PEI at N/P 6 and Stp-cmb-H at different 
N/P ratios. The experiment was performed by Petra Kos (PhD thesis LMU, 2014). 
To examine cytotoxicity, MTT assays were performed at different N/P ratios in parallel to the 
luciferase assay in Neuro2A cells. The metabolic activity values yielded between 80 and 110 
% after pDNA transfection (Figure 30), indicating that none of the oligomers displayed severe 
toxicity under the tested conditions. 
 
Figure 30. Metabolic activity determined with the MTT assay in Neuro2A cells of a) Sdt, Stt, Stp and 
Sph comb structures and b) Stp and Sph linear structures. The experiment was performed by Petra 
Kos (PhD thesis LMU, 2014). 
4.3.4 Introduction of a functionalization site using the Dde-Alloc orthogonality 
In the present work the orthogonality of the Fmoc- and Dde-protecting group was exploited 
for the assembly of comb-type oligomers. Among all synthesized comb structures, Stp-cmb-
H turned out to be the most effective one for pDNA delivery, clearly exceeding the 
transfection efficiency of LPEI. Nevertheless, thinking ahead towards therapeutical 
applications the need for carrier optimization arises, for example in terms of specific tumor 
targeting. In this context, the extension of the orthogonality by introducing a further 
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protecting group is of great interest. Exploiting this synthetic diversity, as a proof of concept 
a PEG-conjugated folic acid (FolA) targeting ligand was attached to the Stp-cmb-H, 
illustrating the possible options of comb structure functionalization. The resulting structure 
C-K(PEG-FolA)-[H-K(Stp)]8-C (Stp-cmb-H-PEG-FolA) is depicted in (Scheme 4). The 
Allyloxycarbonyl (Alloc) protecting group for amines can be removed by reduction with 
palladium catalysts and therefore does not interfere with the base- or acid-driven protective 
group removal [138]. Whereas the cleavage of Alloc in the presence of Dde can be done 
without any precaution, the Dde cleavage with hydrazine in the presence of Alloc is 
performed in the presence of a high excess of allyl alcohol to prevent the premature 
cleavage [130]. Because the cleavage of the Alloc group is much more time-consuming, this 
protection strategy was chosen only for one lysine, which was used for the attachment of 
the targeting ligand. The eight other lysine residues were protected with Dde and were used 
for the attachment of the diaminoethane building blocks for comb assembly (Scheme 5). In 
addition, for investigation of the folic acid-mediated targeting effect a control sequence 
carrying acetylation instead of the targeting ligand was synthesized analogously. 
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Scheme 4. Structure of the comb structure with targeting ligand synthesized with the Dde-Alloc 
strategy.  
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Scheme 5. Last synthesis steps of the targeted comb structure Stp-cmb-H-PEG-FolA, showing the 
structure of the three orthogonal protecting groups Fmoc, Dde and Alloc and the order of their 
cleavage. 
The NMR spectrum of the targeted comb structure, Stp-cmb-H-PEG-FolA, proves the identity 
and the presence of the PEG-linked Folic acid (Figure 31). Nevertheless, the presence of 
peaks belonging to the Fmoc protecting group, indicate difficulties (incomplete Fmoc 
removal) in the synthesis. Also in the HPLC chromatogram a small fraction of Fmoc-
containing product can be detected for the FolA-targeted oligomer but the chromatogram of 
the control sequence with acetate demonstrates that the applied synthesis conditions are 
suitable to obtain products of a higher level of purity (Figure 32). 
 
Figure 31. 
1H-NMR spectrum of Stp-cmb-H-PEG-FolA in D2O verifying the successful attachment of 
the PEG-FolA ligand. 
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Figure 32. HPLC chromatograms of Stp-cmb-H-PEG-FolA (=FolA) and Stp-cmb-H-PEG-Acetate (=Ac 
ctrl) recorded on a RP SunFire C18 column. 
The successful PEG-shielding is demonstrated by an increase of size of pDNA polyplexes of 
the comb structures with PEG-ligand (FolA and Ac ctrl) compared to the original unmodified 
oligomer, as well as the simultaneous decrease of the zeta potential, measured by DLS 
(Figure 33). Despite the PEGylation, which may hinder the electrostatic binding of the 
oligomer and the nucleic acid to some extent, both PEGylated structures display complete 
DNA binding in the agarose gel shift assay at N/P 6 and higher (Figure 34). Finally, the 
functionality of the FolA-targeted ligand was shown by efficient DNA delivery in FolA 
receptor-overexpressing KB cells. The specific uptake via the FolA receptor can be concluded 
from the lack of gene transfer of the control sequence with PEG-shielding, hampering the 
unspecific uptake (Figure 35). 
 
Figure 33. Size (indicated as Z-average) and zeta potential of FolA (= Stp-cmb-H-PEG-FolA) and Ac ctrl 
(= Stp-cmb-H-PEG-acetate) pDNA polyplexes at N/P 12 determined by DLS. 
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Figure 34. DNA binding of FolA (= Stp-cmb-H-PEG-FolA) and Ac ctrl (= Stp-cmb-H-PEG-acetate) at 
increasing N/P ratios determined by agarose gel shift assay. 
 
Figure 35. Luciferase gene transfer of FolA (= Stp-cmb-H-PEG-FolA) and Ac ctrl (= Stp-cmb-H-PEG-
acetate) pDNA polyplexes tested in FolA-receptor overexpressing KB cells at increasing N/P ratios 
without or with addition of the endolysosomotropic molecule chloroquine (CQ). The experiment was 
performed by Petra Kos (PhD thesis LMU, 2014). 
4.4 Comparison of comb and linear topology of oligomers for pDNA delivery 
The results shown in Chapter 4.3 revealed that the comb topology may provide effective 
carriers for pDNA delivery. In the following, the most promising sequences, which were 
those bearing Stp or Sph branches, were compared to corresponding linear structures 
containing the identical type and numbers of amino acids, but with the Stp or Sph building 
- -amino group 
of the oligomer backbone. Therefore, the total number of protonatable amines remains the 
same in both carrier types, but the lengths of oligomer backbone strongly differ.  
4.4.1 Biophysical characterization: DNA condensation, particle size and buffer capacity 
The pDNA complexation ability of the branched and linear oligomers was examined at 
different N/P ratios using the agarose gel shift assay. While the comb structures showed 
partial DNA binding at N/P 3 and complete binding at N/P 6 and higher (Figure 24) the linear 
Stp and Sph sequences showed already complete DNA binding at N/P 3 (Figure 36). To 
investigate the influence of the N/P ratio on the binding capability in more detail, an EtBr 
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exclusion assay was performed increasing the N/P ratio in steps of 0.5 from N/P 0 to 2 and 
bigger steps up to N/P 12 (Figure 37). Except for the Stp containing structures with Ala 
spacer, all linear structures showed a better DNA condensation ability compared to the 
corresponding comb structures. This effect was less pronounced for the structures with 
histidine spacer (Stp-lin-H vs. Stp-cmb-H). The results are in agreement with the data 
obtained in the gel shift assay and demonstrate an advantageous DNA binding for the linear 
structures. However, both comb- and linear-type structures are able to form stable 
polyplexes with pDNA at N/P ratios higher than 5. 
 
Figure 36. pDNA binding ability of Stp and Sph linear structures determined by agarose gel shift assay 
at increasing N/P ratios as indicated. 
 
Figure 37. EtBr exclusion assay of Stp (a-c) and Sph (d-f) comb structures and corresponding linear 
structures with increasing N/P ratios by stepwise addition of the oligomer to pDNA solution at pH 
7.4. a), d) without spacer b), e) Ala spacer c), f) His spacer 
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Particle size and zeta potential of oligomer/pDNA complexes were determined at N/P 12 by 
DLS (Table 7). The mean sizes of the polyplexes of the Stp comb type structures were about 
100 to 130 nm (Table 6). Polyplex sizes were quite similar for the linear structures with a 
range between 85 and 135 nm. For Sph-containing structures slightly bigger sizes were 
observed, in the range of 100 to 170 nm for the comb structures and 115 to 130 nm for the 
linear structures, but revealing again no significant differing effect of the topology on the 
polyplex size. Independent of the building block, the zeta potential of comb structures 
without spacer or Ala spacer displayed a slightly higher zeta potential than the 
corresponding linear structure. The zeta potential was quite similar for His-containing 
structures (Table 7).  
 Z-average [nm] PDI Zeta potential [mV] 
Stp-lin-0 112,9 ± 12,9 0,359 26,2 ± 0,8 
Stp-lin-A 85,8 ± 3,9 0,226 26,0 ± 0,4 
Stp-lin-H 131,6 ± 3,6 0,314 28,7 ± 0,4 
Sph-lin-0 117,4 ± 12,2 0,195 14,6 ± 3,7 
Sph-lin-A 127,9 ± 4,0 0,276 12,4 ± 0,6 
Sph-lin-H 125,3 ± 3,4 0,313 21,8 ± 0,3 
Table 7. Particle sizes (indicated as Z-average), polydispersity index (PDI) and zeta potential (ZP) of 
oligomer/pDNA complexes at N/P 12 measured by DLS. 
Comparing the differential buffer capacities between pH 5.0 and 7.4 in detail, a clear 
difference in the buffering profiles became obvious (Figure 38). For Stp oligomers with four 
protonatable amines in the comb type and three in the linear type, all comb structures 
displayed the highest buffer capacity between pH 5.0 and 6.5, whereas the maximum buffer 
capacity of the linear oligomers was observed between pH 6.5 and 7.4 (Figure 38 a, b). An 
opposite effect could be observed for the Sph oligomers, where four protonatable amines 
are provided in the linear structures and five in the comb structures. Here the linear 
oligomers demonstrated a clearly higher buffer capacity between pH 5.0 and 6.5, whereas 
the highest buffer capacity of the comb oligomers was observed between pH 6.5 and 7.4 
(Figure 38 d, e). As histidine enhances the buffer capacity at pH 6, an additive effect at this 
pH could be observed for the histidine-containing oligomers, so that the already high buffer 
capacity at this pH was further increased for the Stp comb and Sph linear structures, 
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whereas the Stp linear and Sph comb structures consequently showed a broader buffer 
capacity over the whole pH range from 5.0 to 7.4 (Figure 38 c, f). 
 
Figure 38. Comparison of differential buffer capacities of Stp- and Sph-based comb and linear 
structures between pH 5.0 and 7.4. a) Stp oligomers without spacer, b) Stp oligomers with Ala spacer,  
c) Stp oligomers with His spacer, d) Sph oligomers without spacer, e) Sph oligomers with Ala spacer,  
f) Sph oligomers with His spacer. 
4.4.2 Biological evaluation: Cellular association, intracellular uptake, gene transfer and 
cytotoxicty 
To compare the biological efficiency of the Stp and Sph comb and linear oligomers, the 
cellular association of polyplexes was investigated in Neuro2A cells (Figure 39). After one 
hour at 0 °C, the linear structures displayed a higher amount of polyplexes bound to the 
cells. After four hours of incubation, the cellular association was similar for comb and linear 
structures.  
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Next the intracellular uptake of polyplexes was investigated after four hours at 37 °C (Figure 
40). Interestingly and independent of the ethylene amine building block and the spacer 
amino acid, the comb type structures displayed higher intracellular uptake rates than their 
linear counterparts. Cellular uptake was already higher for the comb structures than the 
linear structures after one hour and approximately 3- to 4-fold higher for the Stp combs and 
5- to 11-fold for the Sph combs after four hours. 
The reasons for the discrepancy between cell association and intracellular uptake, and the 
differing effect of oligomers topology remain unclear. Simple biophysical properties such as 
zeta potential can be ruled out as dominating parameters. In the case of Stp-cmb-A, Sph-
cmb-0 and Sph-cmb-A the zeta potential of the comb structures was higher than for the 
linear structures, which correlates with their enhanced cellular internalization. However, for 
the other examined structure pairs the measured zeta potential was similar but the 
enhanced uptake was still observed. 
 
Figure 39. Cellular association of Cy5-labeled DNA/oligomer complexes at N/P 12 after one or four 
hours with Stp or Sph oligomers determined by flow cytometry in Neuro2A cells. Comb structures are 
displayed with solid lines, linear structures with dotted lines. Without spacer = red, Ala spacer = blue 
and His spacer = green. X-
cell counts with according fluorescence signal after appropriate gating. The experiment was 
performed by Petra Kos (PhD thesis LMU, 2014). 
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Figure 40. Cellular internalization of Cy5-labeled DNA/oligomer complexes at N/P 12 after one or 
four hours with Stp or Sph oligomers determined by flow cytometry in Neuro2A cells. Comb 
structures are displayed with solid lines, linear structures with dotted lines. Without spacer = red, Ala 
spacer = blue and His spacer = green. X-
the number of cell counts with according fluorescence signal after appropriate gating. The 
experiment was performed by Petra Kos (PhD thesis LMU, 2014). 
The oligomers were compared in their pDNA transfection efficiency (Figure 41). For Stp 
oligomers, the gene transfer levels of the comb type oligomers were 7- to up to 340-fold 
higher compared to the linear structures (Figure 41 a). The histidine-containing oligomers 
displayed the greatest gene transfer efficiency. Evaluation of the pDNA transfection 
efficiency of Sph comb and linear structures also revealed some higher gene transfer 
efficiency of the comb type oligomers, but compared to the Stp oligomers this effect was 
less pronounced (Figure 41 b). 
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Figure 41. Luciferase gene transfer by comb versus linear carriers. a) Stp and b) Sph oligomers tested 
with pCMVLuc pDNA in Neuro2A cells at N/P ratios 6, 12 and 24. The experiment was performed by 
Petra Kos (PhD thesis LMU, 2014). 
As already demonstrated for the Stp and Sph comb structures (Figure 30) also the linear 
structures displayed mean values of around 80 to 100 % metabolic aciticty in the MTT assay 
at different N/P ratios indicating no severe cytotoxicity under the tested conditions (Figure 
42). 
 
Figure 42. Metabolic activity determined with the MTT assay in Neuro2A cells of Stp and Sph linear 
structures. The experiment was performed by Petra Kos (PhD thesis LMU, 2014). 
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5 DISCUSSION 
5.1 Evaluation of linear oligo(ethanamino)amide carriers of increasing molecular weight 
for pDNA delivery and comparison to linear PEI 
In the present work optimized microwave-assisted solid-phase supported synthesis and the 
artificial amino acids succinyl-tetraethylene pentamine (Stp) [61] or succinyl-pentaethylene 
hexamine (Sph) [66, 68] were applied for the assembly of well-defined linear peptide-like 
carriers for pDNA delivery. The artificial amino acids as well as the transfection agent PEI [25, 
139-141] contain the diaminoethane motif. This protonatable repeat unit is responsible for 
the favorable transfection properties, mediating electrostatic binding with pDNA and 
additional protonation capacity upon cell entry into endolysosomal compartments [127, 
142-145]. The gold standard linear PEI (LPEI), containing approximately 500 (±200) 
protonatable nitrogens [146], obviously has a far larger average polymer size than previously 
synthesized Stp oligomers. In addition both Stp and Sph oligomers differ from LPEI by an 
amide-bonded succinic acid linker after every fifth or sixth ethanamino unit. To address the 
question whether longer linear Stp or Sph oligomers can mimic LPEI in transfection, the 
effect of increasing the MW of linear oligo(ethanamino)amides on pDNA mediated gene 
transfer and cytotoxicity was investigated. Beyond a critical oligomer size - indeed the 
diaminoethane motif containing building blocks (Stp or Sph) enable efficient gene transfer 
without need for further functional modifications. 
DNA complexation studies using agarose gel shift and EtBr based assays showed improved 
binding characteristics with increasing number of Stp units. In agreement with previous 
studies [111] an oligomer with 5 Stp did not show any pDNA binding. The longer the 
synthesized Stp chain, the better pDNA binding was observed. This polyplex stabilization can 
be attributed to multivalent electrostatic interactions between the pDNA with oligomers 
carrying more positive charges per molecule. Interestingly, comparison of the oligomer 
containing 30 Stp units (MW 8.3 kDa) with the same molecule carrying two terminal 
cysteines for further disulfide-based stabilization did not reveal any differences in polyplex 
stabilization and dissociation. This contrasts previous findings with a wide spectrum of 
smaller oligomers where the cysteine modification displayed an essential contribution to 
polyplex stabilization [63, 132]. Similarly, the effect of substituting Stp for Sph, which 
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resulted in enhanced pDNA complexation in studies using oligomers with lower number of 
building block units [66, 68], was attenuated in the case of the long oligomers with 20 or 30 
Stp (or Sph) units per oligomer. -alanine incorporation, as it was 
implemented in the [Stp5-ßA]6-W oligomer, clearly diminished the pDNA binding ability. This 
finding points out that not only the MW and number of positive charges, but also the charge 
density plays an important role for the electrostatic interaction of the polycation with the 
polyanionic nucleic acid. The results of the binding and polyplex stability assays are in 
accordance with the measurements of the particle sizes, indicating that only at a certain 
length threshold (> 10 Stp units) the Stp oligomers are able to form compact nanosized 
particles with pDNA. 
Endosomal protonation is a key prerequisite for the transfection activity of PEI [25, 139-141]. 
Both the number of protonatable amines in a row in one diaminoethane building block [66] 
as well as the number of repeated building block units might influence the buffering profile. 
Measurement of the buffer capacities of Stp oligomers with increasing length, Sph oligomers 
and LPEI resulted in very similar values of around 15-20 % differential protonation between 
pH 5.0 and 7.4, independent of the molecular weight. Previous findings that Sph analogs 
(with 4 protonatable amines in a row) displayed improved endosomal buffering compared to 
Stp oligomers (with 3 protonatable amines in a row) are most likely only applicable to 
smaller oligomers with lower amount of building block units and might not apply for these 
longer structures with 20 or more units. The gene transfer experiments show a clear 
increase of transfection efficiency with increasing MW. Interestingly, Stp15-W with a MW of 
around 4.3 kDa exceeded the LPEI transfection level but only at the highest tested N/P ratio 
of 24. Stp30-W, containing 91 protonatable nitrogens, displayed a greater gene transfer than 
LPEI already at N/P ratio 3, indicating the excellent capability of these carrier systems for 
pDNA delivery. As Stp40-W achieved similar pDNA transfection levels but did not exceed the 
performance of Stp30-W, we assume that an optimum length was reached at around 30 
units and further elongation does not result in a greater benefit. Also the cysteine-
terminated Stp30-W analog did not further increase luciferase expression levels, confirming 
that for these long Stp oligomers the disulfide bond-mediated polyplex stabilization does not 
provide a benefit. According to the findings that exchanging Stp for Sph did not significantly 
alter the buffering capacity and DNA complexation ability of the oligomers Sph20-W and 
Sp30-W, also the luciferase gene transfer was at the same high level as for the original Stp 
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oligomers. The observation that the Stp30- -alanine incorporation after every 
fifth Stp unit clearly reduced the gene transfer activity, underlines the influence of the 
microstructure of the oligomers, especially the charge density determining the nucleic acid 
binding ability. 
Since the cytotoxicity of the cationic polymer PEI is one of the major concerns for the use as 
a carrier for gene delivery, the comparison between LPEI and the new Stp oligomers is 
particularly relevant. PEI is known to cause toxic effects by versatile mechanisms such as 
cytosolic and mitochondrial membrane damage as well as necrotic-like and apoptotic 
changes [123, 124, 147-149]. The CellTiter®Glo cytotoxicity assay revealed an at least 10-fold 
reduction of toxicity for the transfection-competent Stp oligomers in comparison to the 
commonly used LPEI. Cytotoxicity correlates with MW. Not only the lower MW of Stp30-W, 
but also the succinate spacer between the oligoamine units may contribute to the favorable 
biocompatibility of the Stp oligomers over standard PEIs. In fact, previous work 
demonstrated about 10-fold reduced toxicity of randomly branched PEI 25 kDa upon partial 
amidation with propionic or succinic acid [46].  
5.2 Characterization of oligo(ethanamino)amides by capillary electrophoresis and Taylor 
dispersion analysis 
The application of CE to sequence-defined oligo(ethanamino)amides of increasing length by 
our collaboration partners (Xiaoyun Jin, Dr. Laurent Leclercq, Prof. Dr. Hervé Cottet, U, 
Montpellier) turned out to be a useful tool for the analytical characterization of the 
electrophoretic behavior, providing new insights into charge and size distribution as well as 
possible interactions between the oligomers and their environment.  
Electropherograms in acetic acid show a high electrophoretic mobility for all oligomers, as it 
can be expected due to the high extent of protonation at the low pH. Furthermore, it can be 
recognized that the dependence of mobility on molar mass for evenly charged small 
polyelectrolytes is non monotonous. These results are consistent with previous findings 
revealing that small oligomers (MW < 2000) present a larger range of increasing mobility 
with increasing chain length, whereas charged molecules of intermediate MW (2000  
20000) display a slightly decreased mobility [150]. The increase of mobility with molar mass, 
typical for MWs of < 2000, is due to hydrodynamic coupling. Comparing a dimer and a 
monomer, the charge is multiplied by two while the friction coefficient of the dimer is less 
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than twice the friction coefficient of the monomer. Therefore the mobility that results from 
the ratio of charge to friction increases from monomer to dimer. This is true for oligomers 
with MW of ~1000-2000. For higher MWs, the mobility tends to decrease slowly for two 
reasons. First, there is a screening of the previously described hydrodynamic coupling effect 
by the friction of the counter ions. For that reason the friction coefficient tends to become 
proportional to the MW. The other reason is the occurrence of counter ion condensation, 
this means ion pair formation decreasing the effective charge. For higher molar mass 
(typically above MW 20 000), the mobility is independent of the size since both effective 
charge and friction are proportional to the MW. Cottet et al. showed that a change from 
rod-like to coil conformation accompanies the observation of an intermediate oligomer size 
with maximum mobility and the following slight decrease until a constant mobility is reached 
for oligomers or polymers of high MW [150]. 
-aminocaproic acid. The decreasing 
electrophoretic mobility with increasing oligomer length, observed in both buffer solutions 
(acetic acid and -aminocaproic acid), can be explained by counter ion condensation and 
screening of the hydrodynamic coupling that increases the frictional coefficient. However, 
inversed correlation was observed in HEPES buffer, meaning increased mobility with 
increasing oligomer length. This abnormal behavior might be explained by specific 
interactions of HEPES with the oligomer, which at the applied pH of 7.4 offers both cationic 
charges for electrostatic interactions and unprotonated domains for hydrophobic 
interactions or hydrogen bond formation. Interaction with HEPES seems to be much stronger 
with the smallest oligomers, leading to lower mobilities. 
Application of CGE by addition of dextran was expected to show a size-dependant 
electrophoretic mobility. In a gel of 5 % dextran, the mobility of all oligomers was 
significantly decreased and peak broadening was observed likely due to higher resolution in 
molar mass. The desired effect of better resolution with a higher dextran concentration of 
10 % was not observed because at this high dextran concentration peak broadening occured 
and the results were hardly repeatable. Interactions of the large dextran molecules with the 
oligomers have to be taken into account as possible reasons. Application of other polymers 
for gel formation should be considered in the future to improve the size-based separation of 
the oligomers. 
Discussion  82 
The opposing correlations between the electrophoretic mobility and the MW of the analyzed 
oligomers, which were observed in the buffer systems of differing pH values, demonstrate 
the complexity of the possible interactions that can occure between the oligomers and the 
surrounding buffer components. The observed changes of the electrophoretic mobility at 
different pH values allow assumptions on possible conformations, which could be adopted 
by the oligomers in dependence of their protonation status and thus their cationic charge 
density. 
Similar findings were made in TDA, which was used for determination of the hydrodynamic 
radius of the oligomers. First measurements in HBG buffer resulted in quite small Rh values, 
which can be attributed to repulsive interactions with the high concentrated glucose 
lowering the apparent diffusion coefficient. This presumption was verified by much higher 
radius (1.94 nm instead of 0.78 nm for Stp30-W) in HEPES buffer without glucose. The 
expected correlation of increasing hydrodynamic radius with increasing MW could be shown 
for the oligomers with 10, 20 and 30 Stp units, but the longest oligomer with 40 units 
displayed a smaller size, similar to the oligomer consisting of 20 Stp units. This aberration 
could be a consequence of a higher proportion of small impurities in the sample leading to a 
lower average size for the Stp40-W sample. It might be also explained by a conformational 
change at a certain length modifying the size of the oligomer. 
A further interesting aspect in regard to conformational considerations is to set the Rh value, 
determined by TDA experiments, in relation to the contour length, which can be estimated 
with the exact oligomer structure and the length of chemical bonds. The assumption that the 
oligomer Stp30-W has a contour length of around 50 nm, is based on the knowledge of the 
contour length of one diaminoethane unit of polyethylenimine in a semiprotonated state 
(0.29 nm) [127] and the contour length of the amino acid backbone (0.38nm) [151]. In 
relation to the determined diameter of 3.88 nm (determined in HEPES pH 7.3 in TDA) it is 
almost 13-fold larger, which allows the conclusion that the linear oligomers adopt a rather 
coiled form in solution and still leaves the question open, how such a long structure can be 
condensed to such a small diameter. The reason for the appearance of two populations of 
different sizes in some of the buffer solutions also remains unclear but can most likely be 
explained by different conformational assemblies, although to a certain extent polydispersity 
cannot be excluded. 
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Assessing the variation of the hydrodynamic radius at different pH values, an increase of Rh 
values could be observed at acidic pH below 2. This effect is in accordance with the 
knowledge of a conformational change from the entangled gauche conformation in the 
unprotonated and semiprotonated state of PEI, to the stretched, antiperiplanar 
conformation in the fully protonated state, resulting in an increase of the contour length 
from 0.29 nm to 0.38 nm [152]. 
 
Figure 43. Conformational change of the diaminoethane motif in dependence of the protonation 
state. Modified from Wagner [127] and Ziebarth & Wang [153]. 
Although the results obtained by CE and TDA experiments are still in a preliminary state, 
they demonstrate the suitability of these sophisticated techniques to characterize 
oligo(ethanamino)amide carriers and get new insights in their behavior as polycationic 
species. Leclercq et al recently combined TDA and CE for analysis of polyelectrolyte 
complexes [154]. Application of this method for polyplex characterization opens up the 
possibility to determine the charge stoichiometry of the polycationic carrier and the 
polyanionic nucleic acid. In case of polydisperse samples, it could furthermore elucidate 
which population associates preferentially to the DNA and help to quantify the fraction of 
excess free oligomer in the polyplex. The determination of different sizes of disulfide-linked 
di-, oligo- or polymers would present a further interesting aspect, providing deeper insights 
in the physicochemical properties of the polyplexes, which help to further optimize the 
carrier systems. 
5.3 Optimization of comb-like oligomers for pDNA delivery  
Based on the knowledge of structure-activity relationships of an already existing library of 
sequence-defined cationic carriers for pDNA delivery [111], new comb-like structures were 
designed and synthesized by attaching the artificial amino acid Stp to an oligolysine 
backbone and inserting different natural amino acids between the lysines in the backbone 
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(Scheme 3b). Several of the obtained structures containing the spacer amino acids alanine, 
beta-alanine, histidine or tryptophane with or without terminal cysteines were screened for 
DNA transfection efficiency. Based on these results, three structures were chosen for further 
carrier optimization. As previously reported for linear structures [63, 68, 111] also for the 
comb structures the terminal cysteines demonstrated beneficial stabilization of polyplexes 
by means of disulfide formation and were therefore maintained in the synthesis of 
additional structures. The knowledge that histidine enhances endosomal release due to a 
beneficial buffering profile, which could be confirmed by the observed increase of 
transfection efficiency also for the comb structures, led to the selection of a histidine-
containing structure. Corresponding control sequences with an alanine spacer for the 
determination of the specific histidine effect as well as without any spacer molecule, to 
visualize a possible spacer effect, completed the selection. Based on these three backbone 
structures a small library of twelve oligomers was synthesized via attachment of the four 
artificial amino acids Sdt, Stt, Stp and Sph (differing in the numbers of cationizable nitrogens 
from two to five) to the oligolysine backbone. The biophysical properties of the oligomers 
and their performance in biological application were then compared. In analyses of comb 
oligomers with the different oligoamino acid building blocks, the ability of DNA complexation 
was investigated by EtBr assay. The weakest DNA binding was revealed for Sdt oligomers, 
implying that these structures might be the less suitable ones amongst the tested carriers. 
Consistent with the weak DNA binding, pH titrations revealed a less protonated state at pH 
7.4 and therefore potentially less electrostatic interactions with the negatively charged DNA.  
Sdt structures were not able to form small and stable particles. The formation of big 
aggregates of around 2 µm for Sdt-cmb-0 may account for the very low cellular uptake. Also 
polyplexes with Sdt-cmb-A and Sdt-cmb-H displayed rather large particle sizes and only a 
small fraction of cells internalized. Nevertheless, some transfection efficiency was observed 
for the Sdt oligomers in the luciferase assay.  A possible reason might be an improved 
endosomal release based on effective endosomal buffering and protonation. Sdt comb 
oligomers display the highest buffer capacity between pH 5.0 and 7.4 amongst the tested 
oligomers. In contrast, Stt oligomers showed the worst buffering capacity. The particle sizes 
were around 2- fold higher compared to the polyplexes formed with the Stp structures. The 
latter ones resulted in the smallest particles with the highest positive zeta potential. 
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Together with the high buffering capacity the beneficial nanoparticle characteristics mark 
the Stp comb structures as potent carriers for gene delivery.  
The best-performing oligomer in terms of DNA transfection, Stp-cmb-H, was chosen as an 
exemplary structure in order to demonstrate the potential of further functionalization of 
comb-type structures. Taking advantage of the orthogonality of the Dde and Alloc protecting 
-amino groups of the oligolysine backbone can be specifically modified with 
 a proof of this concept a comb structure was 
synthesized resembling Stp-cmb-H but carrying one additional lysine to which a folic acid-
bearing PEG-ligand was attached. Although the complex synthetic procedure requires 
further optimization, the suitability of the strategy and the benefit of the functionalization 
were demonstrated.  
5.4 Comparison of comb and linear topology of oligomers for pDNA delivery 
To investigate which properties can be attributed to the specific comb topology, linear 
control Stp sequences were synthesized and directly compared in terms of biophysical 
properties and biological performance. To further explore to which extent the different 
behavior is a consequence of the topology or an effect of the variation of the protonatable 
ethylenamine building block length, the same comparison was performed with the Sph-
containing comb and linear structures. 
Superior pDNA binding of the histidine-free linear structures was displayed by the EtBr assay, 
whereas for the histidine-containing structures a similar pDNA condensation ability of linear 
and comb structures could be observed, both in case of Stp and Sph based oligomers. A 
possible explanation is that histidine also contributes to the pDNA complexation ability and 
polyplex stabilization of these structures, therefore mitigating the difference in performance 
of comb and linear type. Furthermore, the tests revealed that at N/P 12 the DNA 
condensation was complete for all oligomers, so that this N/P ratio was used for further 
studies aimed at comparing particle size, zeta potential, cellular uptake and association. 
A most prominent distinction of comb and linear structures was found in the buffer capacity 
at the physiological relevant pH range between 5.0 and 7.4. Kataoka et al. proposed the so-
called -
number of protonatable amino ethylene units provide high buffer capacity in this pH range 
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and therefore a high transfection efficiency, while polymers with odd-numbered amino 
ethylene side chains display low buffer capacity and hence also low transfection efficiency. 
This assumption is based on the fact that changes in protonation from pH 7.4 to pH 5.0 occur 
for even-numbered structures, while electrostatic repulsion prohibits further protonation for 
odd-numbered structures, resulting in a lower buffer capacity. This model is confirmed in the 
current study by the comparison of the buffering capacity of Sdt, Stt, Stp and Sph building 
blocks. Sdt and Stp-containing comb structures with even-numbered protonatable amines 
show a higher buffer capacity than the odd-numbered Stt and Sph containing structures. 
Nevertheless, only partial accordance with the hypothetical model can be found in the 
comparison of comb and linear topology. Stp units in the comb sequences provide four 
protonatable amines (even number) and in the linear structures only three (odd number). 
Therefore the total buffer capacity should be higher for the comb structures, while in 
comparison of the Sph combs (five protonatable amines = odd number) with Sph linear 
structures (four protonatable amines = even number) the linear structures were expected to 
provide a higher total buffer capacity. The fact that free amines of the lysine in the linear 
structures result in the same total number of protonatable amines in both structure types 
shows that not the total number, but the intramolecular localization plays a crucial role. In 
both cases, comparing Stp and Sph comb and linear structures, a similar total buffer capacity 
bet -
with regard to the buffering profile. The results clearly demonstrate that an odd number of 
protonatable amines in row leads to a maximum buffer capacity in the pH range from 6.5 to 
7.4 and an even number of protonatable amines results in a maximum buffer capacity at pH 
5.0 to 6.5. Especially the higher buffer capacity from pH 5.0 to 6.5, which corresponds to the 
endosomal pH, may be contributing to an enhanced endosomal release. These findings give 
deeper insight into this phenomenon and contribute to understanding the superior 
performance in gene transfer of structures with higher buffering capacity at the relevant pH 
range. Remarkably, for all types of carriers the histidine-containing sequences displayed the 
highest gene transfer consistent with the general notion that an increased buffer and 
ults in terms of buffer capacity, the Stp 
building block is more beneficial when using it in the comb topology. 
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The comb and linear topology resulted in a further clear difference in regard to cellular 
association and internalization. In the cell association assay performed by incubation at 0 °C 
(to block internalization), after one hour the polyplexes formed with linear structures 
showed an increased cell association compared to the comb structures. After four hours the 
measured cell binding of polyplexes of comb and linear sequences was similar.  Surprisingly, 
all Stp and Sph comb structures displayed an enhanced cellular uptake in comparison to 
their linear counterparts. This trend was observed already at one hour incubation time and 
was clearly visible after four hours. As no remarkable differences could be observed for the 
size and zeta potential of comb and linear structures, these studies clearly demonstrate that 
the uptake process is considerably influenced by the carrier topology. Whether the oligomer 
topology alters the nanoparticle surface exposed in cellular interaction, or whether the 
different free oligomers trigger cell uptake processes in a different manner, remains to be 
investigated. These observations are in agreement with other studies showing that 
nanoparticle shape and surface can have influence on the cellular uptake and binding on the 
cell surface. 
Interestingly, the different transfection efficiencies of oligomers without spacer or with 
alanine spacer indicate that not only the total amount of cationic charges and buffering may 
be important, but also the orientation and distance of the charged domains, which is 
changing the charge density and hence several biophysical properties. 
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6 SUMMARY 
Despite considerable success in the use of viral vectors for gene delivery, limitations in 
connection with the potential for immune reactions and insertional mutagenesis shifted the 
attention towards the application of synthetic carriers with lipids, polymers and peptides as 
most prominent examples. Among the cationic polymers, linear polyethylenimine (LPEI) is 
still a prevalent standard reagent for DNA transfection. A huge number of modifications 
have so far been applied in order to improve the properties of this carrier in terms of 
effectivity and cytotoxicity with partial success, but the eminent drawback of its polydisperse 
nature remains a major concern for a potential use in the clinics.  
In the current doctoral study novel sequence-defined oligo(ethanamino)amide carriers were 
assembled by solid-phase peptide synthesis (SPPS). Artificial oligoamino acids such as 
succinyl-tetraethylene pentamine (Stp) or succinyl-pentaethylene hexamine (Sph) were 
combined with various natural amino acids in defined sequence and topology. The 
monodispersity and precision of the synthesized oligomers allowed the systematic study of 
clear structure-activity relations, such as the effect of increasing MW or backbone topology 
on the most relevant parameters for gene transfer, including pDNA binding, polyplex 
stabilization, cell uptake, endosomal buffering, transfection efficiency and cytotoxicity. 
In the first part the step by step elongation of precise linear oligo(ethanamino)amides 
synthesized via SPPS was carried out. The expectation was that containing only the 
diaminoethane motif but no other functional domains, these oligomers should ideally mimic 
polydispersity and cytotoxicity. Moreover the high gene transfer activity should be 
maintained or even enhanced. The applied strategy demonstrated the influence of 
increasing MW and allowed to determine an optimum carrier length of 30 Stp units 
(representing 90 protonatable nitrogens). This gene carrier based on the diaminoethane 
motif showed six-fold higher transfection efficiency and ten-fold lower cytotoxicity than the 
conventionally used LPEI. 
In the second part of this thesis the effect of topological changes on specific carrier 
properties for pDNA delivery was investigated. By means of SPPS a new comb topology was 
designed, where several different artificial amino acids containing the diaminoethane motif 
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were attached to a lysine backbone. Different spacer amino acids (alanine, beta alanine, 
histidine) were introduced to the lysine backbone and distinct effects could be attributed to 
them. The most profitable modification was the insertion of histidine, which enhanced the 
endosomal buffering due to its protonation of the imidazole group at the physiological 
relevant pH 6. Consequently, the transfection efficiency was significantly increased 
emphasizing the endosomal release as a crucial step among the hurdles of nucleic acid 
delivery. In the next step the most efficient comb oligomers were directly compared to linear 
control sequences to derive more detailed structure-activity relationships and to show the 
explicit effect of the topology. This direct comparison revealed that a change in topology of 
sequence-defined oligoamino acid-based pDNA carriers from linear to comb-like design 
resulted in a distinct change in buffer capacity profile of oligomers and intracellular uptake 
of corresponding pDNA polyplexes. For the Sph oligomers the linear structures showed an 
increased buffer capacity at endosomal pH, but the comb structures displayed a higher 
cellular uptake. These two opposing trends resulted in an only slightly higher transfection 
efficiency of the comb structures. For the Stp oligomers, the comb structures displayed the 
favorable endosomal buffering profile and mediated an enhanced cellular uptake. This 
additive comb benefit contributed to a strongly enhanced efficacy of Stp combs for pDNA 
delivery, determining them as promising candidates for further applications.  
In summary, this doctoral study points out the relevance of two criteria  size and topology  
for the design of oligomer carriers for nucleic acid delivery. The option of designing precise 
sequence-controlled structures offers the opportunity of deriving detailed structure-activity 
relationships. In the future, combining the gained knowledge of the systematic sequence 
variation and modification could allow designing an ideal carrier, comprising most essential 
features  stability during the delivery process, cargo release at the desired place of action 
and biocompatibility  that are crucial for the therapeutical use of synthetic carriers for 
nucleic acid delivery. 
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8 APPENDIX 
8.1 Abbreviatons 
AA   Amino acid 
ACN   Acetonitrile 
Alloc   Allyloxycarbonyl 
AMD   Age-related macular degeneration 
AVET   Adenovirus-enhanced transferrinfection 
boc   Tert- butyloxycarbonyl 
bp   Base pair 
brPEI   Branched polyethylenimine 
CE   Capillary electrophoresis 
cmb   Comb 
CMV   Cytomegalovirus 
CpG   Cytosine phosphatidyl guanine 
CPP   Cell-penetrating peptide 
CQ   Chloroquine 
Da   Dalton 
DAPI   4',6-diamidino-2-phenylindole 
DBU   1,8-diazabicycloundec-7-ene 
DCM   Dichloromethane 
DCVC   Dry column vacuum chromatography 
Dde   N-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl) 
DETA   Diethylene triamine 
DHB   Dihydroxy benzoic acid 
DIPEA   Diisopropylethylamine 
DLS   Dynamic light scattering 
DMBA   Dimethyl-barbituric acid 
DMEM   Dulbecco´s modified eagle´s medium 
DMF   Dimethylformamide 
DNA   Deoxyribonucleic acid 
dsRNA   Double-stranded RNA 
EDTA   Ethylenediamine tetraacetic acid 
EHCO N-(1-aminoethyl)iminobis[N-(oleicyl-cyteinyl-histinyl-1-
Aminoethyl)propionamide] 
EPR   Enhanced permeability and retention 
ESI   Electrospray ionization 
EtBr   Ethidium bromide 
EtOH   Ethanol 
FCS   Fetal calf serum 
FDA   Food and Drug Administration 
Fmoc   9-Fluorenylmethyloxycarbonyl 
FolA   Folic acid 
HBG   HEPES buffered glucose 
HBTU 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate 
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HEPES   N-(2-hydroxyethyl)piperazine-N´-(2-ethanesulfonic acid) 
HOAc   Acetic acid 
HOBt   1-hydroxybenzotriazole 
HPC   Hydroxypropylcellulose 
HPLC   High-performance liquid chromatography 
IEX   Ion exchange 
lin   Linear  
LNA   Locked nucleic acid 
LMW   Low molecular weight 
LPEI   Linear polyethylenimine 
Luc   Luciferase 
MALDI-TOF  Matrix assisted laser desorption ionization  time of flight 
MeOH   Methanol 
miRNA   MicroRNA 
mRNA   Messenger RNA 
MS   Mass spectrometry 
MTBE   Tert-butyl methylether 
MTT   Methylthiazolyldiphenyl-tetrazolium bromide 
MW   Molecular weight 
N/P    (protonable) nitrogens/phosphates 
NCL   Native chemical ligation 
NEM   N-ethylmorpholine 
NMP   N-methylpyrrolidone 
NMR   Nuclear magnetic resonance 
Npys   3-nitropyridylsulfenyl 
ODN   Oligodeoxynucleotide 
PAA   Polyamidoamine 
PAMAM  Poly(amidoamine) dendrimer 
PDI   Polydispersity index 
pDNA   Plasmid DNA 
PEG   Polyethylene glycol 
pCMVLuc Plasmid encoding firefly luciferase under the control of CMV promotor 
PEHA   Pentaethylene hexamine 
PEI   Polyethylenimine 
PLL   Poly(L-lysine) 
PMO   Phosphorodiamidate morpholino oligomer 
PPI   Polypropylenimine 
PyBOP   Benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate 
Pys   Pyridylsulfenyl 
RISC   RNA-induced silencing complex 
RLU   Relative light units 
RNA   Ribonucleic acid 
RNAi   RNA interference 
RP-HPLC  Reversed phase high-performance liquid chromatography 
RPMI   Cell culture medium developed in the Roswell Park Memorial Institute 
RT   Room temperature 
SCID   Severe combined immunodeficiency 
SD   Standard deviation 
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Sdt   Succinyl-diethylentriamine 
SEC   Size exclusion chromatography 
siRNA   Small interfering RNA 
SNALP   Stabilized nucleic acid lipid particle 
Sph   Succinyl-pentaethylenhexamine 
SPPS   Solid-phase peptide synthesis 
Stp   Succinyl-tetraethylenpentamine 
Stt   Succinyl-triethylentetramine 
TBE   Tris-boric acid-EDTA buffer 
TCEP   Tris(2-carboxyethyl)phosphine 
TDA   Taylor dispersion analysis 
TEA   Triethylamine 
TEPA   Tetraethylene pentamine 
TETA   Triethylene tetramine 
TFA   Trifluoroacetic acid 
TFE   Trifluoroethanol 
THF   Tetrahydrofuran 
TIS   Triisopropylsilane 
TLC   Thin layer chromatography 
TP-10   Transportan-10 
UV   Ultra violett 
VEGF   Vascular endothelial growth factor 
8.2 List of all oligomers 
8.2.1 Long linear oligo(ethanamino)amide carriers 
Compound 
Id 
Sequence Calculated 
molecular weight 
Detected 
molecular weight[a] 
Protonatable 
amines 
681 Stp5-W 1561,02 1566,6[b] 16 
643 Stp10-W 2917,82 2939,7[c] 31 
644 Stp15-W 4274,61 4294,9[c] 46 
645 Stp20-W 5650,56 n.d.[d] 61 
554 Stp30-W 8345,0 n.d.[d] 91 
555 Stp40-W 11058,59 - 121 
556 [Stp5- 6-W 8876,51 - 91 
682 C-Stp30-W-C 8551,29 - 91 
683 Sph20-W 6492,77 - 81 
684 Sph30-W 9637,04 - 121 
[a] determined by MALDI-TOF mass analysis, [b] [M+H]+ [c] [M+Na]+ [d] n.d. = not detectable 
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8.2.2 Comb structure oligomers 
Compound 
Id 
Sequence Code Calculated 
molecular weight  
Protonatable 
amines 
545 C-[K(Stp)]4-C - 1822,43 13 
547 C-[H-K(Stp)]4-C - 2370,98 13 
623 A-[K(Stp)]8-A - 3356,42 25 
627 C- -K(Stp)]8-C Stp-cmb-  3989,18 25 
621 C-[W-K(Stp)]8-C Stp-cmb-W 4910,23 25 
686 A-[H2-K(Stp)]8-A - 5550,65 25 
553 C-[H2-K(Stp)]8-C - 5614,78 25 
687 C-[H2-K(Stp)]12-C - 8340,09 37 
632 C-[K(Sdt)]8-C Sdt-cmb-0 2731,47 17 
633 C-[A-K(Sdt)]8-C Sdt-cmb-A 3300,09 17 
634 C-[H-K(Sdt)]8-C Sdt-cmb-H 3828,58 17 
635 C-[K(Stt)]8-C Stt-cmb-0 3076,01 25 
636 C-[A-K(Stt)]8-C Stt-cmb-A 3644,63 25 
637 C-[H-K(Stt)]8-C Stt-cmb-H 4173,13 25 
622 C-[K(Stp)]8-C Stp-cmb-0 3420,55 33 
551 C-[A-K(Stp)]8-C Stp-cmb-A 3989,18 33 
552 C-[H-K(Stp)]8-C Stp-cmb-H 4517,67 33 
629 C-[K(Sph)]8-C Sph-cmb-0 3765,1 41 
630 C-[A-K(Sph)]8-C Sph-cmb-A 4333,72 41 
631 C-[H-K(Sph)]8-C Sph-cmb-H 4862,21 41 
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8.2.3 Linear control sequences 
Compound 
Id 
Sequence Code Molecular weight 
[g/mol] 
Protonatable 
amines 
625 C-(Stp-K)8-C Stp-lin-0 3420,55 33 
626 C-(A-Stp-K)8-C Stp-lin-A 3989,18 33 
628 C-(H-Stp-K)8-C Stp-lin-H 4517,67 33 
648 C-(Sph-K)8-C Sph-lin-0 3765,1 41 
649 C-(A-Sph-K)8-C Sph-lin-A 4333,72 41 
650 C-(H-Sph-K)8-C Sph-lin-H 4862,21 41 
 
8.3 Analytical data 
8.3.1 NMR spectra 
1H-NMR spectra were recorded either at 400 or 500 MHz in deuterium oxide. 
Id:681             Sequence: Stp5-W 
 
-2.7 (m, 20H, -CO-CH2-CH2-CO-), 2.7 - -3.8 (m, 
80H, -CH2- Tepa), 4.5-4.6 (m, 1H, H tryptophane), 7.1-7.7 (m, 5H aromatic H, tryptophane) 
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Id:643           Sequence: Stp10-W 
 
Id:644           Sequence: Stp15-W 
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Id:645           Sequence: Stp20-W 
 
Id:554           Sequence: Stp30-W 
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Id:555           Sequence: Stp40-W 
 
Id:556               Sequence: [Stp5- 5-W 
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Id:682                Sequence: C-Stp30-W-C 
 
Id:683                      Sequence: Sph20-W 
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Id:684                      Sequence: Sph30-W 
 
 
NMR spectra of Boc-protected diaminoethane motif containing building blocks 
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Id: 545                Sequence: C-[K(Stp)]4-C 
- -2.6 (m, 16H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 64H, -CH2- Tepa), 4.0-
cysteine) 
Id: 626                Sequence: A-[K(Stp)]8-A 
-1.8 (m, 64 , ), 2.4 -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -
), 3.1-3.6 (m, 128H, -CH2- Tepa), 4.0- ) 
Id: 627          Sequence: C- -K(Stp)]8-C 
- -2.6 (m, 48H, -CO-CH2-CH2-CO-, -alanine), 
2.6 - -alanine), 3.1-3.6 (m, 128H, -CH2- Tp), 4.0-4.6 
 
Id: 621           Sequence: C-[W-K(Stp)]8-C 
- -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 128H, -CH2- Tepa), 4.0-4.6 (m, 16H, 
 7.1-7.7 (m, 40H aromatic H, tryptophane) 
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Id: 686          Sequence: A-[H2-K(Stp)]8-A 
-1.8 (m, -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -
-3.6 (m, 128H, -CH2- Tepa), 4.0-
lysine, histidine, alanine) 
Id: 553           Sequence: C-[H2-K(Stp)]8-C 
-1.8 (m, -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 128H, -CH2- Tepa), 4.0-
lysine, cysteine, histidine), 7.3-7.5 (s,16H histidine), 8.6-8.7 (s, 16H histidine) 
Id: 632                Sequence: C-[K(Sdt)]8-C 
- -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 64H, -CH2- Deta), 4.0-
cysteine) 
Id: 633            Sequence: C-[A-K(Sdt)]8-C 
1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -
-3.6 (m, 64H, -CH2- Deta), 4.0-
cysteine, alanine) 
Id: 634            Sequence: C-[H-K(Sdt)]8-C 
1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 64H, -CH2- Deta), 4.0-
lysine, cysteine, histidine), 7.3-7.5 (s, 8H histidine), 8.6-8.7 (s, 8H histidine) 
Id: 635                 Sequence: C-[K(Stt)]8-C 
1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 96H, -CH2- Teta), 4.0-
cysteine) 
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Id: 636             Sequence: C-[A-K(Stt)]8-C 
1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -
-3.6 (m, 96H, -CH2- Teta), 4.0-
cysteine, alanine) 
Id: 637             Sequence: C-[H-K(Stt)]8-C 
- -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 96H, -CH2- Teta), 4.0-
lysine, cysteine, histidine), 7.3-7.5 (s, 8H histidine), 8.6-8.7 (s, 8H histidine) 
Id: 622                Sequence: C-[K(Stp)]8-C 
- -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 128H, -CH2- Tepa), 4.0-
cysteine) 
Id: 551            Sequence: C-[A-K(Stp)]8-C 
- -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -
-3.6 (m, 128H, -CH2- Tepa), 4.0-4
lysine, cysteine, alanine) 
Id: 552            Sequence: C-[H-K(Stp)]8-C 
- -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 128H, -CH2- Tepa), 4.0-
lysine, cysteine, histidine), 7.3-7.5 (s, 8H histidine), 8.6-8.7 (s, 8H histidine) 
Id: 629               Sequence: C-[K(Sph)]8-C 
1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
steine), 3.1-3.6 (m, 160H, -CH2- Peha), 4.0-
cysteine) 
Id: 630           Sequence: C-[A-K(Sph)]8-C 
1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -
1-3.6 (m, 160H, -CH2- Peha), 4.0-
lysine, cysteine, alanine) 
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Id: 631           Sequence: C-[H-K(Sph)]8-C 
1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
1-3.6 (m, 160H, -CH2- Peha), 4.0-
lysine, cysteine, histidine), 7.3-7.5 (s, 8H histidine), 8.6-8.7 (s, 8H histidine) 
Id: 625                  Sequence: C-(Stp-K)8-C 
- -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 128H, -CH2- Tepa), 4.0-
cysteine) 
Id: 626              Sequence: C-(A-Stp-K)8-C 
- -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -
3.1 -3.6 (m, 128H, -CH2- Tepa), 4.0-
lysine, cysteine, alanine) 
Id: 628             Sequence: C-(H-Stp-K)8-C 
(ppm): 1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 128H, -CH2- Tepa), 4.0-
lysine, cysteine, histidine), 7.3-7.5 (s, 8H imidazole of histidine), 8.6-8.7 (s, 8H histidine) 
Id: 648                 Sequence: C-(Sph-K)8-C 
1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 160H, -CH2- Peha), 4.0-
cysteine) 
Id: 649             Sequence: C-(A-Sph-K)8-C 
1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -
-3.6 (m, 160H, -CH2- Peha), 4.0-
lysine, cysteine, alanine) 
Id: 650             Sequence: C-(H-Sph-K)8-C 
1.0 - -2.6 (m, 32H, -CO-CH2-CH2-CO-), 2.6 -3.1 (m, 
-3.6 (m, 160H, -CH2- Peha), 4.0-
lysine, cysteine, histidine), 7.3-7.5 (s, 8H histidine), 8.6-8.7 (s, 8H histidine) 
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8.3.2 Additional HPLC chromatograms of long linear Stp and Sph oligo(ethanamino)amides, 
comb structure oligomers and linear control sequences 
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